Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E17.01 EPS (ttm)10.26 Insider Own0.10% Shs Outstand734.13M Perf Week1.42%
Market Cap128.15B Forward P/E13.61 EPS next Y12.83 Insider Trans0.00% Shs Float733.56M Perf Month14.06%
Income7.72B PEG2.51 EPS next Q2.99 Inst Own80.20% Short Float0.81% Perf Quarter21.78%
Sales22.99B P/S5.57 EPS this Y13.10% Inst Trans-2.09% Short Ratio1.66 Perf Half Y3.58%
Book/sh40.59 P/B4.30 EPS next Y3.95% ROA10.10% Target Price184.58 Perf Year22.08%
Cash/sh51.88 P/C3.36 EPS next 5Y6.79% ROE25.90% 52W Range131.83 - 174.70 Perf YTD20.21%
Dividend4.60 P/FCF19.66 EPS past 5Y20.50% ROI13.00% 52W High-0.08% Beta1.22
Dividend %2.64% Quick Ratio3.90 Sales past 5Y8.10% Gross Margin81.90% 52W Low32.41% ATR2.76
Employees19200 Current Ratio4.10 Sales Q/Q7.70% Oper. Margin42.60% RSI (14)78.88 Volatility1.55% 1.68%
OptionableYes Debt/Eq1.16 EPS Q/Q10.50% Profit Margin33.60% Rel Volume0.75 Prev Close174.01
ShortableYes LT Debt/Eq1.01 EarningsFeb 02 AMC Payout38.70% Avg Volume3.57M Price174.56
Recom2.30 SMA205.66% SMA5011.65% SMA20011.35% Volume2,670,584 Change0.32%
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Feb-08-16Reiterated Argus Buy $202 → $185
Jan-20-16Initiated Credit Suisse Outperform $205
Dec-15-15Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-04-15Initiated Wells Fargo Market Perform
Oct-29-15Reiterated UBS Buy $168 → $180
Sep-01-15Initiated Raymond James Mkt Perform
Jul-31-15Reiterated RBC Capital Mkts Outperform $185 → $190
Jul-31-15Reiterated Deutsche Bank Buy $192 → $195
Jul-31-15Reiterated Barclays Equal Weight $180 → $185
May-28-15Reiterated Deutsche Bank Buy $200 → $192
Apr-22-15Reiterated UBS Buy $175 → $185
Apr-22-15Reiterated RBC Capital Mkts Outperform $178 → $185
Oct-29-14Reiterated Argus Buy $140 → $185
Feb-26-17 11:20AM  3 Stocks You Don't Have to Babysit at Motley Fool
Feb-23-17 05:06PM  AbbVie Stronger Bet Than Gilead, Amgen At Least Until 2020: Leerink
01:45PM  In 'groundbreaking' deal, Harvard Pilgrim negotiates contracts to save on two pricey drugs at bizjournals.com
09:31AM  Amgen Signs Value-Based Deal for Enbrel at Investopedia
08:00AM  Big Pharma Quietly Enlists Leading Professors to Justify $1,000-a-Day Drugs
Feb-22-17 06:21PM  Who Could Buy Bristol-Myers Squibb? at Motley Fool
01:30PM  Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease at Motley Fool
12:21PM  Genmab and J&J's cancer drug set for blockbuster sales this year
10:37AM  Keytruda: Mercks Immuno-Oncology Blockbuster Drug
10:30AM  Amgen Gets EU Nod for Monthly Repatha Dose at Investopedia
09:30AM  The Zacks Analyst Blog Highlights: Amgen, Procter & Gamble, Bank of America, Netflix and Honda
06:43AM  Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
Feb-21-17 04:48PM  Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?
04:00PM  Repatha® (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option PR Newswire
09:34AM  Top Research Reports for Amgen, Bank of America, and Proctor & Gamble
08:54AM  Study Reveals PCSK9 Drugs Can Save Heart Disease Patients at Motley Fool
07:36AM  How Amgens Kyprolis Is Positioned in Second-Line Multiple Myeloma Segment
Feb-20-17 12:15PM  Roche Sues Amgen Over Avastin Biosimilar Drug at Investopedia
10:36AM  Repatha Represents a Solid Growth Opportunity for Amgen in 2017
09:06AM  Amgens Neutropenia Drugs May See Falling Revenues in 2017
07:36AM  Enbrel Strengthens Its Position in Rheumatology and Dermatology Segments
Feb-18-17 01:04PM  AMGEN INC Financials
Feb-17-17 03:34PM  Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
10:36AM  Amgen Is Managing the Life Cycle of Its Mature Nephrology Drugs in 2017
09:12AM  Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.
09:07AM  Parsabiv Is Expected to Boost Amgens Revenues in 2017
07:37AM  Prolia Expected to Be a Significant Growth Driver for Amgen in 2017
Feb-16-17 05:35PM  Amgen Commits to Reaching Its Long-Term Financial Targets in 2018
04:41PM  Don't Count on Valeant's New Drug to Save the Day at Motley Fool
03:36PM  Amgen Estimates Modest Revenue Performance in 2017
11:18AM  Health Care ETF Has Been Ailing
09:20AM  Why Amgen's Becoming One of My Top Dividend Stocks to Buy at Motley Fool
Feb-15-17 06:35PM  Cramer fires back at naysayers: Here's your proof that th...
05:59PM  Proof the rally is real
05:19PM  Biotech boom?
12:22PM  Amgen Applies for Leukemia Drug Label Expansion at Investopedia
09:48AM  Want to Get In on Biotech? Check Out These 3 Stocks at Motley Fool
08:31AM  Amgen Looking to Broaden Leukemia Drug Blincyto's Label
Feb-14-17 05:07PM  AMGEN INC Files SEC form 10-K, Annual Report
09:00AM  Amgen Submits Supplemental Biologics License Application For BLINCYTO® (Blinatumomab) In Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia PR Newswire
Feb-13-17 05:30PM  Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma
Feb-10-17 09:55AM  Major Biotechs Scare Off Loads of Short Sellers
08:38AM  Biotech ETFs Powered by Q4 Earnings
Feb-09-17 04:56PM  Regeneron Defies Light Q4 Sales, Eylea Outlook On Amgen-Rivaling LDL Win
02:01PM  Regeneron: Whiplash! at Barrons.com
01:11PM  Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (ADR) (SNY) Obtain Suspension of Injunction for Cholesterol Drug Sales at Insider Monkey
11:09AM  Regeneron (REGN) Misses on Q4 Earnings & Sales, View Bleak
10:56AM  Judge Lifts Ban on Amgen Cholesterol Drug Rival at Investopedia
09:05AM  Acorda, Amgen and Regeneron Lead Premarket Biotech Movers
08:31AM  Regeneron forecasts 2017 U.S. Eylea sales growth below estimates
08:17AM  A Heart-Stopping Patent Injunction Stay For Sanofi at Forbes
Feb-08-17 07:02PM  [$$] Appeals Court Allows Sanofi, Regeneron to Continue Selling Cholesterol Drug at The Wall Street Journal
05:45PM  Gilead tanks on weak forecast
05:33PM  Regeneron, Sanofi Temporarily Stave Off Ban Of Amgen-Rivaling LDL-Buster
04:49PM  Federal appeals court decision will keep Regeneron/Sanofi drug at center of patent dispute on market, for now at MarketWatch
04:39PM  Judge: Regeneron can keep selling cholesterol drug
04:14PM  Regeneron (REGN) Q4 Earnings: Will the Stock Disappoint?
12:48PM  FDA Approves Amgen, Inc. (AMGN) Drug For Treating Secondary Hyperparathyroidism at Insider Monkey
12:03PM  Why Coherus Biosciences Is Falling Today at Motley Fool
11:39AM  Coherus Biosciences Inc (CHRS) Could Be A Discount Entry On The Pullback at Insider Monkey
10:48AM  Amgen Gets FDA Approval for Kidney Drug Parsabiv at Investopedia
09:02AM  Amgen's Secondary Hyperparathyroidism Drug Approved in U.S.
08:23AM  Better Buy: Amgen Inc. vs. Celgene at Motley Fool
06:45AM  Biotech Stock Roundup: Amgen, Gilead Report 4Q Results, ARIAD Seeks EU Nod for Brigatinib
03:25AM  Drugmaker Sanofi sees weak 2017 earnings, not in hurry for M&A
Feb-07-17 07:05PM  Cramer: The right time to buy more oil stocks at CNBC
06:20PM  U.S. FDA approves Amgen drug for secondary hyperparathyroidism Reuters
06:13PM  FDA Approves Amgen's Parsabiv (Etelcalcetide), First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On Hemodialysis PR Newswire
02:08PM  Amgen, Inc. :AMGN-US: Earnings Analysis: 2016 By the Numbers : February 7, 2017
12:50PM  Whats Next For Esperion Therapeutics Inc (ESPR)? at Insider Monkey
09:06AM  Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More
Feb-06-17 12:40PM  Priced like an automaker, sputtering Gilead shares lure value bets
10:44AM  Amgen, Inc. :AMGN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017
10:10AM  Company News for February 06, 2017
08:02AM  Amgen Stock Buoyed By Positive Repatha Study at Investopedia
12:42AM  [$$] Good News for Amgen Is Good News for Biotech at The Wall Street Journal
Feb-05-17 07:23AM  Trump's Plan to Lower Drug Costs Is a Fairy Tale at Motley Fool
Feb-03-17 06:11PM  Trading Friday's rally: 6 plays at CNBC
05:49PM  Why Morgan Stanley, Amgen, and Tableau Software Jumped Today at Motley Fool
05:05PM  Banks lead stock surge as investors hope for regulation cuts
04:32PM  Why The Medicines Company Rocketed Higher Today at Motley Fool
04:24PM  Amgen's LDL-Buster Boosts The Medicines Co., But Regeneron Slides
04:15PM  BetterInvesting Magazine Releases April Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use PR Newswire
04:04PM  Amgen Announces Appointment of Charles M. Holley Jr. to Board of Directors PR Newswire
03:38PM  Why Esperion Therapeutics, Inc. Is Soaring Today at Motley Fool
03:15PM  Amgen: Who Says Biotech's Dead? at Barrons.com
12:43PM  [$$] Good News for Amgen Is Good News for Biotech at The Wall Street Journal
12:16PM  Repatha Will Test the New Drug Pricing Reality at Bloomberg
11:08AM  Amgen Q4 Earnings Beat Street Forecasts at Investopedia
10:47AM  Dow Retakes 20,000 As Visa, Goldman, Rally; Amazon Sinks, But Amgen Soars
10:25AM  Stocks Open Higher As Payrolls Surge, Dow Passes 20,000 Again
08:38AM  Are Options Traders Betting on a Big Move in Amgen (AMGN) Stock?
08:01AM  Early movers: AMZN, CLX, AN, HSY, F, AMGN & more at CNBC
06:59AM  Amgen (AMGN) Q4 Earnings Top; Repatha Positive in CV Study
04:40AM  Edited Transcript of AMGN earnings conference call or presentation 2-Feb-17 10:00pm GMT
Feb-02-17 07:20PM  Fast Money traders discuss how to trade Amgen and Amazon earnings at CNBC
06:50PM  [$$] Amgen Sees Positive Results in Repatha Study at The Wall Street Journal
06:15PM  Amgen fourth quarter profit tops Street view, cholesterol news lifts shares
06:14PM  Amgen 4th-qtr profit tops Street view, cholesterol news lifts shares
05:49PM  Amgen CEO: Will work with Trump to lower drug prices
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for the prevention of skeletal-related events; Repatha to treat coronary artery diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Erenumab for the prevention of chronic migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; AMJEVITA to treat psoriatic arthritis and polyarticular juvenile idiopathic arthritis, as well as ankylosing spondylitis and moderate-to-severe rheumatoid arthritis; ABP 215 for biosimilar candidates; and ABP 980 to treat human epidermal growth factor receptor 2-positive early breast cancer. The company's other marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products for use to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; and Bayer HealthCare Pharmaceuticals Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
de Carbonnel FrancoisDirectorSep 09Option Exercise71.645,000358,20021,171Sep 13 06:21 PM
Such Annette LouiseVP, Finance and CAOAug 02Sale174.593,000523,7587,183Aug 03 08:14 PM
Balachandran MadhavanEVP, OperationsMay 04Sale154.1230,0004,623,62455,996May 05 08:16 PM
BALTIMORE DAVIDDirectorApr 29Sale157.213,312520,68432,350May 03 07:12 PM
BALTIMORE DAVIDDirectorMar 30Option Exercise50.445,000252,20037,350Mar 31 06:01 PM
HERRINGER FRANK CDirectorMar 14Option Exercise50.445,000252,20030,608Mar 16 06:48 PM
COFFMAN VANCE DDirectorMar 09Option Exercise50.445,000252,20043,447Mar 10 06:55 PM
Bradway Robert AChairman, CEO and PresidentMar 02Option Exercise50.4484,0004,236,960447,102Mar 04 06:07 PM
Bradway Robert AChairman, CEO and PresidentMar 02Sale146.4820,0002,929,566383,102Mar 04 06:07 PM
UNP Union Pacific Corporation daily Stock Chart
UNP [NYSE]
Union Pacific Corporation
IndexS&P 500 P/E21.25 EPS (ttm)5.07 Insider Own0.20% Shs Outstand819.20M Perf Week-1.51%
Market Cap88.26B Forward P/E16.95 EPS next Y6.36 Insider Trans-3.93% Shs Float810.59M Perf Month-2.43%
Income4.23B PEG1.90 EPS next Q1.25 Inst Own80.70% Short Float0.96% Perf Quarter7.85%
Sales19.94B P/S4.43 EPS this Y-7.70% Inst Trans-1.22% Short Ratio2.08 Perf Half Y14.17%
Book/sh24.33 P/B4.43 EPS next Y12.77% ROA7.60% Target Price113.22 Perf Year38.35%
Cash/sh1.63 P/C66.01 EPS next 5Y11.21% ROE20.90% 52W Range75.15 - 111.38 Perf YTD3.92%
Dividend2.42 P/FCF41.22 EPS past 5Y8.60% ROI13.60% 52W High-3.27% Beta0.74
Dividend %2.25% Quick Ratio0.80 Sales past 5Y0.40% Gross Margin81.20% 52W Low43.38% ATR1.97
Employees42919 Current Ratio1.00 Sales Q/Q-0.80% Oper. Margin36.50% RSI (14)49.25 Volatility1.99% 1.62%
OptionableYes Debt/Eq0.75 EPS Q/Q6.30% Profit Margin21.20% Rel Volume1.23 Prev Close106.70
ShortableYes LT Debt/Eq0.71 EarningsJan 19 BMO Payout43.20% Avg Volume3.76M Price107.74
Recom2.30 SMA20-0.57% SMA501.49% SMA20013.05% Volume4,624,849 Change0.97%
Jan-20-17Reiterated RBC Capital Mkts Sector Perform $111 → $115
Jan-20-17Reiterated Cowen Market Perform $98 → $109
Jan-18-17Initiated Buckingham Research Neutral
Jan-09-17Upgrade Barclays Equal Weight → Overweight $104 → $122
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-24-16Initiated Seaport Global Securities Buy $100
Oct-21-16Downgrade RBC Capital Mkts Outperform → Sector Perform $107 → $98
Oct-20-16Downgrade Cowen Outperform → Market Perform $99 → $91
Jul-20-16Downgrade Deutsche Bank Buy → Hold $94
Jun-03-16Upgrade Morgan Stanley Equal-Weight → Overweight $90
May-19-16Initiated Credit Agricole Sell
Apr-22-16Reiterated RBC Capital Mkts Outperform $90 → $95
Apr-18-16Downgrade UBS Buy → Neutral $89 → $88
Feb-23-16Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-22-16Upgrade BofA/Merrill Neutral → Buy
Jan-25-16Reiterated Argus Buy $110 → $80
Jan-22-16Reiterated Stifel Buy $95 → $78
Jan-22-16Reiterated RBC Capital Mkts Outperform $93 → $82
Jan-22-16Reiterated Deutsche Bank Buy $93 → $87
Jan-21-16Reiterated Cowen Outperform $95 → $89
Feb-23-17 03:28PM  Union Pacific Police Pursues Prestigious CALEA Accreditation PR Newswire
09:05AM  How Canadian Pacifics Stand up to Rival Canadian National
Feb-22-17 09:06AM  These Commodity Groups Pushed BNSF Railways Carloads
07:36AM  The Story behind Union Pacifics Intermodal Volumes
04:21AM  Union Pacific (UNP) Up 3.4% Since Earnings Report: Can It Continue?
Feb-21-17 04:58PM  Expeditors (EXPD) Beats on Q4 Earnings, Revenues
03:35PM  Union Pacifics Carloads Are Facing These Growth Limits
02:06PM  How Higher Coal Volumes Are Lifting Up Norfolk Southern
12:45PM  Unusual Activity: Bulls target PBI & UNP
Feb-20-17 08:01AM  5 Trade Ideas for Tuesday: Commerce Bancshares, Cirrus Logic, McCormick, Ulta Beauty and Union Pacific
Feb-17-17 09:07AM  Berkshires BNSF and the Latest in Local Manufacturing
Feb-16-17 01:10PM  Is CSX Corporation Stock Gearing Up for Another Huge Year After a Fantastic 2016? at Motley Fool
12:19PM  Union Pacific Tops Fortune's Most Admired in Industry PR Newswire
10:36AM  These Key Commodity Groups Drove Canadian Pacifics Carloads
Feb-15-17 01:38PM  Veteran Favored for CSX Helm Could Push Extreme Makeover
09:30AM  The Zacks Analyst Blog Highlights: ConocoPhillips, Emerson Electric, Union Pacific, Occidental Petroleum and Cardinal Health
09:07AM  Why Union Pacifics Carloads Jumped in the 5th Week of 2017
Feb-14-17 03:36PM  Behind Union Pacifics Intermodal Volumes
03:10PM  Stock Research Reports for Union Pacific, ConocoPhillips & Emerson Electric
02:06PM  Norfolk Southerns Carloads: Coal Could Be Bouncing Back
12:28PM  Let the US Freight Rail Traffic Revival Begin
09:00AM  10 Best Dividend Stocks in the Dow Averages at Kiplinger
Feb-13-17 10:36AM  Why Genesee and Wyomings European Revenue Fell in 4Q16
07:37AM  Why Genesee and Wyomings Australian Revenue Rose in 4Q16
Feb-10-17 05:09PM  Strong Volumes Drive Genesee and Wyomings North American Revenue
Feb-09-17 01:04PM  UNION PACIFIC CORP Financials
07:36AM  Boosted by Coal Volumes, Canadian Pacifics Carloads Rose
Feb-08-17 10:00AM  Union Pacific Could See a Significant Pullback in 2017
09:07AM  Why CHRWs Robinson Fresh Segmental Revenue Slumped in 4Q16
09:06AM  How Does Kansas City Southerns Intermodal Traffic Compare?
Feb-07-17 03:05PM  Why Did CHRWs North American Surface Transport Net Revenue Slide in 4Q16?
09:08AM  How Union Pacifics Intermodal Volumes Compare
08:00AM  Union Pacific Corporation CFO Rob Knight to Address the Stifel and Barclays Investor Conferences PR Newswire
07:36AM  A Look at Union Pacifics Carloads in the 4th Week of 2017
07:04AM  3 Attractive Income Stocks Whose Dividends Could Double at Motley Fool
Feb-06-17 04:29PM  US and Canada Freight Rail Weekly Traffic Up, Mexican Volume Down
Feb-03-17 04:16PM  UNION PACIFIC CORP Files SEC form 10-K, Annual Report
09:14AM  3 Dividend Stocks Trading At 10% Discount Or More at Insider Monkey
Feb-02-17 04:17PM  UNION PACIFIC CORP Files SEC form 8-K, Change in Directors or Principal Officers
01:51PM  Union Pacific Corporation Announces a $3.1 Billion Capital Plan for 2017 and Declares First Quarter 2017 Dividend PR Newswire
07:35AM  Coal Volumes Fall, Canadian Pacifics Carloads Rise
Feb-01-17 12:02PM  Industrial ETF Investors! Look at Trump, Not Soft Earnings
07:36AM  Huge Rise in Coal Boosts BNSF Railways Carloads
Jan-31-17 09:08AM  Why Did Union Pacifics Intermodal Volumes Rise?
07:39AM  What Boosted Union Pacifics Carloads?
Jan-30-17 05:06PM  Why Norfolk Southerns Carloads Increased
03:07PM  Traffic Rises 8%: Could US Freight Rail Pick up in 2017?
12:50PM  Union Pacific Is Chugging Right Along
09:30AM  Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins
07:00AM  What it takes to get a Corona from Mexico to a U.S. heartland bar Reuters
Jan-27-17 03:59PM  What it takes to get a Corona from Mexico to a U.S. heartland bar Reuters
10:43AM  Union Pacific vs. CSX Earnings: How Do They Stack Up? at Motley Fool
09:07AM  Why Norfolk Southerns General Merchandise Revenue Slid in 4Q16
07:38AM  Why Norfolk Southerns Coal Revenues Slumped in 4Q16
Jan-26-17 06:00PM  Stocks Trumps 20 percent Mexico import tax, border wall could hurt and ones he might help at bizjournals.com
09:30AM  Zacks Investment Ideas feature highlights: Abb, Applied Materials, Broadcom, LyondellBassel and Union Pacific
Jan-25-17 11:27AM  Norfolk Southern (NSC) Beats on Q4 Earnings, Misses Sales
11:27AM  Union Pacific Employees Achieve Safest Year in Company History PR Newswire
08:15AM  Post Earnings Coverage as Union Pacific's Q4 Results Beat Market Estimates Accesswire
07:36AM  Why Canadian Pacifics Carloads Slumped in Second Week of 2017
Jan-24-17 04:38PM  Trump revives pipelines: Who wins & loses?
01:18PM  ETFs with exposure to Union Pacific Corp. : January 24, 2017
12:28PM  How high-speed rail tracks are expected to pass through Diridon Station at bizjournals.com
10:57AM  Why Canadian Pacific Railway Is the Top Bet in the Railroad Group
09:30AM  The Zacks Analyst Blog Highlights: IBM, Union Pacific, Yahoo, General Motors and Google
Jan-23-17 01:31PM  Union Pacific Corp. : UNP-US: Dividend Analysis : November 30th, 2016 (record date) : By the numbers : January 23, 2017
01:30PM  Q4 Scorecard & Research Reports for IBM & Union Pacific
10:37AM  How Coal Volumes Impacted Union Pacifics Carloads
07:39AM  Investors Insights into Union Pacifics Intermodal Volumes
07:39AM  US and Canadian Freight Rail Traffic Up, Mexican Traffic Down
Jan-22-17 07:35PM  With Trump Renewing Vow to Renegotiate NAFTA, Here's Some of the Most Vulnerable Companies
Jan-20-17 04:28PM  Union Pacific Corporation Earnings Rise as Cost Cuts Offset Lower Freight Shipments at Motley Fool
11:17AM  Union Pacific Corp. :UNP-US: Earnings Analysis: Q4, 2016 By the Numbers : January 20, 2017
07:38AM  Why CSXs Merchandise Revenue Rose in 4Q16
07:08AM  Today's Top Supply Chain and Logistics News From WSJ at The Wall Street Journal
12:19AM  [$$] Business Watch at The Wall Street Journal
Jan-19-17 07:01PM  Cramer: The 3 Rail Stocks Are Sells, but That's Not the Real Story
06:41PM  Edited Transcript of UNP earnings conference call or presentation 19-Jan-17 1:45pm GMT
06:35PM  CSX shares jump 20 pct as activist reignites rail merger hopes
04:51PM  Union Pacific cost cuts offset declining shipments in 4Q
03:52PM  Union Pacific Corp. (UNP) Up on Q4 Earnings Beat
03:26PM  CSXs 4Q16 Earnings Beat Analysts Estimates, But It Fell 3.2%
03:10PM  US STOCKS-Wall St falls as investors ready for Trump's inauguration
12:49PM  US STOCKS-Wall St dips as investors ready for Trump's inauguration
12:38PM  Stocks Dip Ahead Of Inauguration, But Netflix, Tesla, Railroads Climb
12:07PM  Union Pacific CEO- "we are opposed to" major railroad mergers
11:40AM  CSX: This Train Has Left the Station at Barrons.com
11:35AM  US STOCKS-Wall St slips as countdown to Trump's swearing-in begins
10:45AM  Union Pacific Upside May be Limited at Investopedia
10:35AM  A Closer Look at Canadian Pacifics Intermodal Volume Growth
10:31AM  Railroad stocks rally as CSX poised for best gains in 36 years at MarketWatch
10:25AM  US stock indexes still treading water; bond yields climb
10:12AM  Union Pacific Shares Rise After Fourth-Quarter Profit Beats Expectations
10:06AM  CSX Jumps After Activists Team to Target Railroad -- Plus Jim Cramer's Take
09:50AM  US STOCKS-Wall St flat as countdown to Trump's swearing-in begins
09:45AM  Union Pacific profit beats estimates, "optimistic" about 2017
09:42AM  Union Pacific (UNP) Beats on Q4 Earnings
09:38AM  [$$] Union Pacific Boosted by Easing Commodities Slump at The Wall Street Journal
09:06AM  Whats Driving the Decline in Canadian Pacifics Carloads?
08:15AM  Post Earnings Coverage as CSX Revenue Climbed 9% Driven by Extra Week Accesswire
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates railroads in the United States. It offers transportation services for agricultural products, including grains, commodities produced from grains, and food and beverage products; automotive products, such as finished vehicles and automotive parts; and chemicals comprising industrial chemicals, plastics, fertilizers, petroleum and liquid petroleum gases, crude oil, and soda ash. The company also provides transportation services for coal, petroleum coke, and biomass; industrial products consisting of construction products, minerals, consumer goods, metals, lumber, paper, and other miscellaneous products; and intermodal import and export container traffic. Its rail network includes 32,070 route miles linking the Pacific Coast and Gulf Coast ports with the Midwest and Eastern United States gateways. Union Pacific Corporation was founded in 1862 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Card Andrew H JRDirectorJan 25Option Exercise24.257,400179,45022,400Jan 26 10:44 AM
Card Andrew H JRDirectorJan 25Sale109.534,000438,12918,400Jan 26 10:44 AM
MCCONNELL MICHAEL WDirectorDec 09Option Exercise24.257,400179,45026,410Dec 12 10:56 AM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Option Exercise39.1327,0681,059,287234,784Dec 12 03:30 PM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Sale104.9423,1982,434,398222,062Dec 12 03:30 PM
MCCONNELL MICHAEL WDirectorDec 09Sale105.157,400778,11919,010Dec 12 10:56 AM
ROGEL STEVEN RDirectorNov 22Option Exercise24.257,400179,45011,400Nov 23 10:51 AM
ROGEL STEVEN RDirectorNov 22Sale100.517,400743,7474,000Nov 23 10:51 AM
DUREN DIANE KEVP CHIEF ADMIN OFFICER & CORPNov 18Sale98.982,840281,103128,701Nov 21 02:14 PM
Scott Cameron AEVP & CHIEF OPERATING OFFICEROct 07Option Exercise66.006,484427,94471,320Oct 11 08:58 AM
Scott Cameron AEVP & CHIEF OPERATING OFFICEROct 07Sale98.446,484638,28564,836Oct 11 08:58 AM
KNIGHT ROBERT M JREVP & CHIEF FINANCIAL OFFICERSep 07Sale97.005,000485,00032,723Sep 09 11:09 AM
KNIGHT ROBERT M JREVP & CHIEF FINANCIAL OFFICERSep 01Sale95.2410,000952,41537,723Sep 02 03:51 PM
DUREN DIANE KEVP & CORPORATE SECRETARYJun 03Sale85.462,500213,650131,541Jun 06 12:25 PM
HOPE RICHARDS JUDITHDirectorMar 11Option Exercise24.257,400179,45031,940Mar 14 11:35 AM
HOPE RICHARDS JUDITHDirectorMar 11Sale81.154,000324,60427,940Mar 14 11:35 AM
BIIB Biogen Inc. daily Stock Chart
BIIB [NASD]
Biogen Inc.
IndexS&P 500 P/E16.86 EPS (ttm)16.91 Insider Own0.10% Shs Outstand215.66M Perf Week-1.72%
Market Cap61.49B Forward P/E12.71 EPS next Y22.44 Insider Trans-14.06% Shs Float214.71M Perf Month4.35%
Income3.70B PEG2.68 EPS next Q5.00 Inst Own89.00% Short Float0.88% Perf Quarter-10.37%
Sales11.45B P/S5.37 EPS this Y10.30% Inst Trans-1.26% Short Ratio1.07 Perf Half Y-7.82%
Book/sh56.05 P/B5.09 EPS next Y6.91% ROA17.00% Target Price321.72 Perf Year8.68%
Cash/sh22.70 P/C12.56 EPS next 5Y6.29% ROE32.20% 52W Range223.02 - 333.65 Perf YTD0.55%
Dividend- P/FCF16.20 EPS past 5Y27.40% ROI21.00% 52W High-14.54% Beta0.78
Dividend %- Quick Ratio2.30 Sales past 5Y17.80% Gross Margin87.10% 52W Low27.85% ATR6.74
Employees7400 Current Ratio2.60 Sales Q/Q1.20% Oper. Margin45.00% RSI (14)54.78 Volatility2.67% 2.11%
OptionableYes Debt/Eq0.54 EPS Q/Q-20.60% Profit Margin32.30% Rel Volume0.99 Prev Close284.75
ShortableYes LT Debt/Eq0.54 EarningsJan 26 BMO Payout0.00% Avg Volume1.77M Price285.13
Recom2.00 SMA202.55% SMA500.79% SMA200-0.48% Volume1,764,300 Change0.13%
Feb-07-17Upgrade Citigroup Neutral → Buy
Dec-29-16Reiterated Raymond James Strong Buy $375 → $386
Dec-09-16Reiterated Stifel Hold $291 → $298
Nov-08-16Initiated Mizuho Buy $290
Nov-07-16Upgrade Piper Jaffray Neutral → Overweight
Nov-07-16Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-16Downgrade Jefferies Buy → Hold
Jun-29-16Initiated Bernstein Outperform
Jun-07-16Downgrade Citigroup Buy → Neutral
Feb-25-16Initiated Citigroup Buy $345
Jan-20-16Initiated Credit Suisse Neutral
Jan-07-16Initiated Standpoint Research Buy $360
Dec-04-15Resumed Wells Fargo Outperform
Oct-22-15Reiterated H.C. Wainwright Buy $380 → $360
Sep-09-15Initiated Jefferies Buy
Sep-01-15Initiated Raymond James Strong Buy $400
Aug-11-15Initiated H.C. Wainwright Buy $380
Jul-27-15Upgrade Bernstein Mkt Perform → Outperform $436 → $385
Jul-27-15Reiterated RBC Capital Mkts Outperform $525 → $450
Jul-27-15Reiterated Argus Buy $450 → $360
Feb-24-17 07:35AM  Ring the Register With These Upcoming Spinoffs
Feb-23-17 05:06PM  Teva Is Expected to See a Fall in Its Profit Margins in 2017
08:02AM  Here's Why Celgene's Latest Drug Is So Exciting at Motley Fool
Feb-22-17 09:15AM  Did Biogen Inc. Shoot Itself in the Foot? at Motley Fool
Feb-21-17 03:40PM  Top pharma lobbyist casts Biogen as the anti-Shkreli during drug price Q&A at bizjournals.com
Feb-20-17 10:30AM  Celgene MS Drug Reports Positive Phase 3 Data at Investopedia
08:24AM  3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter at Motley Fool
07:37AM  This Keeps Driving Sanofis Growth
07:36AM  Nordic Nanovector sees interest in its Non-Hodgkin Lymphoma treatment
Feb-19-17 11:41AM  Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands? at Motley Fool
Feb-16-17 09:40PM  Shkreli defends drug prices, spars with protesters at heated UMass Boston event at bizjournals.com
09:37PM  Tesaro sees a $5B market opportunity for its cancer drug at bizjournals.com
09:27AM  Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback
Feb-15-17 07:34PM  Another Potential Alzheimer's Disease Treatment Bites the Dust: What's Next? at Motley Fool
05:29PM  Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference Business Wire
04:18PM  Merck's Alzheimer's Drug Fails; Are Biogen, Roche, AstraZeneca Next?
10:46AM  Merck Halts Late-Stage Alzheimers Drug Trial at Investopedia
07:18AM  Bioverativ's hemophilia hopes
07:00AM  Another Alzheimer's Drug Study Fails. This Time It's Merck's. at Forbes
Feb-13-17 03:52PM  Key Presenters At Leerink's Healthcare Conference
02:25PM  Regeneron: It's All Riding On Dupixent at Barrons.com
09:00AM  Biogens Spinraza Faces Insurance Coverage Hurdles at Investopedia
Feb-12-17 07:43AM  A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Disease at Motley Fool
Feb-10-17 04:14PM  Is Biogen a Risky Stock? at Motley Fool
09:55AM  Major Biotechs Scare Off Loads of Short Sellers
08:38AM  Biotech ETFs Powered by Q4 Earnings
Feb-09-17 09:05AM  Humana to limit coverage of pricy Biogen drug at bizjournals.com
Feb-08-17 05:31PM  What's Behind Bioverativ's Spin-Out, and Should You Buy? at Motley Fool
01:04PM  BIOGEN INC. Financials
06:45AM  Biotech Stock Roundup: Amgen, Gilead Report 4Q Results, ARIAD Seeks EU Nod for Brigatinib
Feb-07-17 04:53PM  Biogen's Slow Rebound Prompts A Vetr Downgrade
04:20PM  Caterpillar, Biogen, CSX, Big-Box Stores In Analyst Crosshairs
04:01PM  Biogen to Present at the Leerink Partners 6th Annual Global Healthcare Conference Business Wire
09:04AM  The Market In 5 Minutes: GM And Gap Earnings, Retail Sales Data
08:30AM  In an Ironic Twist, Generics Take Aim at Teva Pharmaceutical at Motley Fool
06:46AM  Biogen upgraded by Citigroup
Feb-06-17 10:41AM  Chardan Analyst Suggests An AveXis-Ionis Pair Trade
08:45AM  Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More
Feb-03-17 03:55PM  Biogen Faces Federal Probes for Drug Prices, Rebates at Investopedia
11:03AM  Why Forward Pharma A/S Stock Surged 107% in January at Motley Fool
05:55AM  Hunting down the years 5 hottest M&A targets at MarketWatch
Feb-02-17 05:55PM  Biogen Reveals Federal Investigation Into Pricing, Rebate Payments -6.20%
05:32PM  Biogen: What Now? at Barrons.com
05:09PM  Biogen subpoenaed by federal government over MS drug prices at bizjournals.com
04:51PM  Biogen Trails Merck, Lilly In Alzheimer's; Hemophilia Spinoff Begins Trading
03:54PM  [$$] Bioverativ: New Spinoff and Attractive Target at Barrons.com
12:30PM  ETFs with exposure to Biogen, Inc. : February 2, 2017
11:13AM  Biogen Cancels Autoimmune Drug Deal With Tanabe at Investopedia
10:40AM  5 Drugmakers Battle Over the $10 Billion Hemophilia Market at Motley Fool
08:02AM  What Could Make Biogen Crash? at Motley Fool
07:35AM  Understanding Celgenes Operational Performance Projections for 2017
06:27AM  Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data
Feb-01-17 08:52AM  Drug Stocks to Report Q4 Earnings on Feb 2: MRK & AMGN
07:38AM  Biogen's hemophilia business spin-off will trade on its own starting Thursday at MarketWatch
07:30AM  Biogen Completes Separation of Global Hemophilia Business, Bioverativ Business Wire
Jan-31-17 11:15AM  Biogens hemophilia spinoff launches this week. Heres what you need to know. at bizjournals.com
10:37AM  Spinraza: First Approved Therapy for Spinal Muscular Atrophy in the US
09:45AM  Unlike Silicon Valley, Biopharma's Top Execs React to Trump Migration Ban With Universal Silence
09:08AM  Biosimilar Segment May Drive Biogens Revenue Growth
07:39AM  Tysabri Witnessed Robust Growth in the Number of Patients in 2016
Jan-30-17 05:06PM  Biogen Continues Its Dominance in the Multiple Sclerosis Segment
03:28PM  Biogen Reported Modest Revenue Growth in 4Q16
02:36PM  Celgenes Financial Performance in 2016: Strong Growth in Volumes
09:43AM  Biogen, Inc. :BIIB-US: Earnings Analysis: 2016 By the Numbers : January 30, 2017
09:30AM  The Zacks Analyst Blog Highlights: AT&T, Biogen, Qualcomm, Facebook and Royal Caribbean
Jan-27-17 02:28PM  Biogen Inc Makes Up for Lackluster Revenue Growth at Motley Fool
01:22PM  Q4 Scorecard and Analyst Reports for AT&T, Biogen & Qualcomm
10:45AM  Biogen 4Q Net $2.99 a Share Vs $3.77 Last Year at Investopedia
Jan-26-17 04:47PM  Biogen Sidesteps Q4, 2016 Sales Misses On Strong Ex-Hemophilia Guide
02:50PM  Edited Transcript of BIIB earnings conference call or presentation 26-Jan-17 1:00pm GMT
01:21PM  Biotech ETFs: Is It Time To Buy? at Barrons.com
12:50PM  Biogen Rallies Despite Mixed Revenue Guidance
10:15AM  Biogen earnings lift shares, but concerns about multiple sclerosis drug sales persist at bizjournals.com
09:50AM  Why Biogen is Flying at Barrons.com
09:32AM  Biogen (BIIB) Q4 Earnings Top Estimates; '17 Sales View Soft
09:30AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Celgene and Bristol-Myers Squibb
08:05AM  Biogen MS Drug Tecfidera Gets Liver Injury Warning at Investopedia
08:03AM  Early movers: CMCSA, F, LUV, CAT, PHM, BIIB & more at CNBC
08:00AM  Biogen (BIIB) Beats on Q4 Earnings; Misses Sales
07:07AM  Q4 2016 Biogen Inc Earnings Release - Before Market Open
07:01AM  3 Top Biotech Stocks You Can Still Buy With the Dow at 20,000 at Motley Fool
07:00AM  [$$] Biogen Profit Skids, Revenue Grows Less Than Expected at The Wall Street Journal
06:45AM  Biogen tops 4Q profit forecasts
06:41AM  Biogen profit drops 22 pct due to Tecfidera-related costs
06:37AM  Biogen Profit Beats Estimates as CEO Takes the Helm at Bloomberg
06:35AM  BIOGEN INC. Files SEC form 8-K, Results of Operations and Financial Condition
06:30AM  Biogen Reports 2016 Revenues of $11.4 Billion Business Wire
Jan-25-17 03:47PM  5 Stocks to Watch Before the Market Opens Tomorrow
02:30PM  What to look for when Biogen reports earnings on Thursday at bizjournals.com
02:29PM  Possible liver injury added to label of Biogen MS drug Reuters
11:51AM  Bristol-Myers Squibb May Report Strong Revenue Performance for 2017
11:25AM  What to Expect From Major Health Care Stocks Reporting This Week
10:26AM  Perrigo's (PRGO) Generic Version of Topicort Okayed by FDA
09:08AM  Drug Stock Earnings to Watch on Jan 26: BIIB, CELG & BMY
06:59AM  Earnings Preview: What To Expect From Biogen On Thursday at Forbes
Jan-24-17 06:10PM  LogMeIn and Bioverativ Set to Join the S&P MidCap 400; Others to Join S&P SmallCap 600 PR Newswire
05:42PM  Better Buy: Biogen Inc. vs. Gilead Sciences Inc. at Motley Fool
08:47AM  Top Biosimilar Drug Companies at Investopedia
Jan-23-17 01:30PM  [video]5 Reasons Celgene Should Buy Biogen
12:40PM  Celgene Estimates Robust Revenue in 2017
Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies. The company's Phase III clinical trial products comprise GAZYVA for the treatment of front-line indolent non-hodgkin's lymphoma; and Aducanumab and E2609 for Alzheimer's disease. Its Phase II clinical trial products include BIIB074 for trigeminal neuralgia, lumbosacral radiculopathy, and erythromelalgia; BAN2401 for Alzheimer's disease; Opicinumab (anti-LINGO-1) for MS; TYSABRI for acute ischemic stroke; rAAV-XLRS for X-linked juvenile retinoschisis; BG00011 (STX-100) for idiopathic pulmonary fibrosis; and Dapirolizumab pegol and BIIB059 (Anti-BDCA02) for lupus. The company's Phase I clinical trial products comprise BIIB061 for MS; BIIB054 for Parkinson's disease; BIIB067 (IONIS-SOD1Rx) for amyotrophic lateral sclerosis; and BIIB068 (BTK Inhibitor) for autoimmune disease. It has collaboration agreements with AbbVie, Inc.; Acorda Therapeutics, Inc.; Applied Genetic Technologies Corporation; Eisai Co., Ltd.; Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and University of Pennsylvania. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PANGIA ROBERT WDirectorJan 09Option Exercise52.225,450284,59922,078Jan 10 04:15 PM
PANGIA ROBERT WDirectorJan 09Sale295.395,4501,609,87616,628Jan 10 04:15 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffDec 01Sale296.534814,2337,360Dec 05 04:34 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 04Sale311.9426281,7287,579Oct 05 04:24 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 03Sale313.00380118,9407,841Oct 04 05:02 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 01Option Exercise0.001,98209,154Oct 04 05:02 PM
DORSA CAROLINEDirectorSep 22Option Exercise53.6427,5701,478,85544,663Sep 26 04:24 PM
DORSA CAROLINEDirectorSep 22Sale314.0027,5708,656,98017,093Sep 26 04:24 PM
SCANGOS GEORGE AChief Executive OfficerJul 21Sale280.0015743,96054,779Jul 22 05:03 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 06Sale290.00555160,9502,402Jun 07 04:09 PM
SCANGOS GEORGE AChief Executive OfficerJun 03Sale290.00842244,18054,936Jun 06 08:14 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 02Option Exercise0.001,64303,491Jun 06 08:48 PM
SCANGOS GEORGE AChief Executive OfficerJun 01Sale287.97487140,24155,778Jun 02 04:39 PM
SCANGOS GEORGE AChief Executive OfficerMay 31Sale290.003,368976,72056,265Jun 02 04:39 PM
SCANGOS GEORGE AChief Executive OfficerMay 25Sale280.0015743,96059,633May 27 08:59 AM
SCANGOS GEORGE AChief Executive OfficerMay 02Sale274.74487133,79859,790May 04 05:03 PM
Koppel AdamEVP, Strategy and Bus. Dev.Apr 06Sale275.0010228,0501,848Apr 07 05:03 PM
SCANGOS GEORGE AChief Executive OfficerApr 06Sale280.0015743,96060,277Apr 07 05:01 PM
Artavanis-Tsakonas SpyridonEVP, Chief Scientific OfficerApr 02Option Exercise0.0097503,609Apr 05 05:06 PM
SCANGOS GEORGE AChief Executive OfficerApr 01Sale258.83487126,05060,434Apr 05 05:02 PM
UNH UnitedHealth Group Incorporated daily Stock Chart
UNH [NYSE]
UnitedHealth Group Incorporated
IndexDJIA S&P500 P/E22.49 EPS (ttm)7.25 Insider Own0.50% Shs Outstand948.48M Perf Week-0.36%
Market Cap154.66B Forward P/E15.33 EPS next Y10.64 Insider Trans-2.86% Shs Float934.79M Perf Month1.13%
Income7.02B PEG1.40 EPS next Q2.17 Inst Own88.90% Short Float0.76% Perf Quarter7.52%
Sales184.84B P/S0.84 EPS this Y20.60% Inst Trans-0.11% Short Ratio1.90 Perf Half Y17.58%
Book/sh40.20 P/B4.06 EPS next Y11.91% ROA5.80% Target Price184.85 Perf Year36.88%
Cash/sh11.00 P/C14.83 EPS next 5Y16.09% ROE19.00% 52W Range115.82 - 164.97 Perf YTD1.89%
Dividend2.50 P/FCF26.53 EPS past 5Y8.90% ROI11.40% 52W High-1.16% Beta0.64
Dividend %1.53% Quick Ratio- Sales past 5Y12.70% Gross Margin- 52W Low40.79% ATR2.54
Employees230000 Current Ratio- Sales Q/Q9.00% Oper. Margin7.00% RSI (14)54.54 Volatility1.56% 1.32%
OptionableYes Debt/Eq0.86 EPS Q/Q38.10% Profit Margin3.80% Rel Volume0.72 Prev Close162.60
ShortableYes LT Debt/Eq0.67 EarningsJan 17 BMO Payout32.20% Avg Volume3.75M Price163.06
Recom1.50 SMA200.90% SMA501.09% SMA20012.27% Volume2,707,062 Change0.28%
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Upgrade Cantor Fitzgerald Hold → Buy
Nov-30-16Upgrade Mizuho Neutral → Buy $178
Nov-30-16Reiterated RBC Capital Mkts Outperform $168 → $175
Nov-09-16Downgrade Mizuho Buy → Neutral
Oct-19-16Reiterated Mizuho Buy $160 → $169
Jul-22-16Upgrade Argus Hold → Buy
Jul-20-16Reiterated RBC Capital Mkts Outperform $157 → $165
Jul-19-16Reiterated Mizuho Buy $156 → $160
Jun-16-16Initiated Bernstein Outperform
Jun-13-16Reiterated Mizuho Buy $156 → $156
Apr-20-16Reiterated Mizuho Buy $150 → $156
Apr-19-16Reiterated FBR Capital Outperform $130 → $145
Mar-15-16Reiterated Mizuho Buy $131 → $150
Dec-16-15Initiated Credit Suisse Outperform
Nov-20-15Reiterated Mizuho Buy $155 → $131
Nov-19-15Reiterated FBR Capital Outperform $135 → $130
Oct-02-15Initiated Citigroup Buy
Sep-16-15Initiated JP Morgan Overweight
Sep-09-15Resumed Morgan Stanley Overweight $140
Feb-24-17 04:33PM  [$$] Trump to Meet With Insurance Executives on Repeal of Affordable Care Act at The Wall Street Journal
12:12PM  JPMorgan Fund Boosts Retirement Accounts With Hot Stocks
Feb-23-17 06:29PM  Dow Jones Leads Market Gains on Thursday
04:01PM  Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday
12:39PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of UnitedHealth Group Inc. and Advises Investors with Losses to Contact the Firm Business Wire
Feb-22-17 05:02PM  Health giant to lay off 119 in Denver area at bizjournals.com
10:36AM  Top Research Reports for February 22, 2017
09:59AM  Since the Merger With Cigna Seems Doomed, What Are We to Think of Anthem?
09:27AM  US Market Indexes Higher to Start the Week
Feb-21-17 05:24PM  UnitedHealth Group Commences Exchange Offer to Acquire Surgical Care Affiliates, Inc. Business Wire
04:33PM  Dow logs 8th gain in a row as energy, defensive sectors power record close at MarketWatch
04:30PM  10 Biggest HMOs in USA at Insider Monkey
04:01PM  Wal-Mart, UnitedHealth Dominate DJIA Tuesday
10:10AM  Company News for February 21, 2017
Feb-20-17 01:13PM  What You Need To Know About DoJ's Whistleblower Lawsuit Against UnitedHealth
11:38AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of UnitedHealth Group Incorporated (UNH) PR Newswire
09:13AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UnitedHealth Group Incorporated - UNH PR Newswire
Feb-19-17 07:45AM  17 Provisions That Will Disappear if Obamacare Is Repealed at Motley Fool
Feb-18-17 04:52PM  UIC prof: Could your Fitbit data be used to deny you health insurance? at bizjournals.com
Feb-17-17 06:33PM  Stock market resumes record run to cap week, with late-session push at MarketWatch
04:27PM  UnitedHealth, Health Insurers Fall As DOJ Joins Whistleblower Suit
04:26PM  Stocks Close Higher; UnitedHealth Drags The Dow
03:20PM  DOJ: UnitedHealth improperly overcharged medicare
01:55PM  These Louisville firms are some of Fortune's most admired companies at bizjournals.com
01:46PM  UnitedHealth Hits 52-Week High on Solid Results, SCAI Deal
01:45PM  UnitedHealth shares plunge 4%, but Wall Street analysts respond with a shrug at MarketWatch
01:30PM  Stocks Quietly Mixed In Afternoon; Skyworks Breaks Out, Celgene Bases
12:55PM  Stocks Recover From Early Losses; Nvidia Breaks Key Support But Snaps Back
12:22PM  Today's charts: UnitedHealth, Humana, Aetna, Anthem shares fall
11:26AM  United Healthcare Whistleblower Suit Provides 'Interesting' Investment Opportunity
11:01AM  UnitedHealth's stock tumbles to lead Dow losers after DoJ joins whistleblower lawsuit at MarketWatch
10:43AM  Dow Threatens To End Win Streak; Apple On Track For New Closing High
08:49AM  US STOCKS-Wall St set to slip at open as rally loses momentum
07:40AM  Why Is UnitedHealth (UNH) Up 4.2% Since the Last Earnings Report?
06:47AM  UPDATE 1-UnitedHealth sued by U.S. government over Medicare charges Reuters
12:53AM  PRESS DIGEST- New York Times business news - Feb 17 Reuters
Feb-16-17 06:57PM  U.S. Justice Dept joins whistleblower lawsuit against UnitedHealth -law firm Reuters
05:02PM  Andreas Halvorsen Gains 4 Positions in 4th Quarter
02:49PM  Stock market retreats from records as Trump ends news conference at MarketWatch
11:18AM  Health Care ETF Has Been Ailing
11:14AM  Insurance Megadealers Need to Get Creative at Bloomberg
10:30AM  FORTUNE Survey Rates UnitedHealth Group Worlds Most Admired Company in Insurance and Managed Care for 2017 Business Wire
Feb-15-17 02:00PM  New Children's Storybook about Good Deeds Raises Funds to Help Families Pay for Child Medical Costs Business Wire
Feb-14-17 01:04PM  UNITEDHEALTH GROUP INC Financials
11:45AM  Headline Risk Haunts PBMs As Drug Pricing Debate Intensifies
11:30AM  United Health Foundation Announces Two New Partnerships and Nearly $2.5 Million in Funding to Support Hartford Families Business Wire
10:36AM  Aetna, Humana call off $34 billion deal
10:22AM  Billionaire Bueno, UnitedHealth's Latin America chairman, dies
08:26AM  UnitedHealth Group, Inc. breached its 50 day moving average in a Bullish Manner : UNH-US : February 14, 2017
Feb-13-17 05:19PM  Republicans keep changing when Obamacare will be repealed yet health insurers have a deadline coming up at MarketWatch
11:00AM  ACOs Gain Momentum As Tom Price Takes Helm At HHS at Forbes
09:30AM  Zacks Industry Outlook Highlights: Molina Healthcare, Centene, WellCare Health Plans and UnitedHealth Group
Feb-12-17 07:41AM  Can You Guess How Many Americans Want Obamacare Repealed and Replaced Right Now? at Motley Fool
Feb-10-17 05:05PM  Colorado officials OK UnitedHealthcare acquisition of Rocky Mountain Health Plans at bizjournals.com
10:37AM  Cigna: A Healthy Pick, Deal or No Deal at Barrons.com
06:02AM  How to Trade 5 Health Insurers Now That Mergers Are Being Blocked
Feb-09-17 05:01PM  Vetr Crowd Downgrades UnitedHealth
06:50AM  UnitedHealth Group Board Authorizes Payment of Quarterly Dividend to Shareholders Business Wire
04:38AM  Anthem-Cigna health insurance merger rejected by judge
01:30AM  US judge blocks Anthem-Cigna health insurance merger
Feb-08-17 04:25PM  UNITEDHEALTH GROUP INC Files SEC form 10-K, Annual Report
12:54PM  We can change Medicare without hurting Americans the answer lies in this plan at MarketWatch
08:00AM  More Evidence Backs Medicare's Bundled Fees For Joint Replacements at Forbes
Feb-07-17 11:02AM  3 Stocks for the Next Dow Rally at Barrons.com
09:30AM  The Zacks Analyst Blog Highlights: General Electric, Altria, UnitedHealth, Caterpillar and Phillips 66
09:10AM  Top Analyst Upgrades and Downgrades: Best Buy, Caterpillar, Nokia, UnitedHealth, Wal-Mart and Many More
07:45AM  Blue Cross hires former CEO of UnitedHealth's startup insurer at bizjournals.com
Feb-06-17 05:55PM  US Market Indexes Lower on Monday
05:28PM  Top Research Reports for February 6, 2017
04:01PM  Verizon, Home Depot Lead Dow Lower Monday
10:00AM  Funding Available for Kansas Organizations Improving Access to Health Care in Rural and Frontier Areas Business Wire
Feb-03-17 04:56PM  Obamacare signups on federal exchange dip to 9.2 million at MarketWatch
04:32PM  ClearBridge Mutual Fund Manager Sticks To Stocks With Rising Dividends
09:22AM  Cluster of Insider Buying at Clinical-Stage Vaccine Company, Massive Insider Selling at Analog Chip Giant, Plus Other Insider Trading at Insider Monkey
Feb-02-17 09:38PM  Real Estate Leads Gains on Thursday
04:35PM  Stocks slip on Trump diplomacy woes; S&P 500 bucks weak trend at MarketWatch
04:01PM  Caterpillar, Boeing Weigh on DJIA Thursday
11:21AM  The 10 cheapest, fastest-growing and most beloved Dow stocks at MarketWatch
11:20AM  UnitedHealth Is 'Only Way to Play' ACA Repeal: More Squawk From Jim Cramer
10:21AM  Top Ranked Momentum Stocks to Buy for February 2nd
08:00AM  UnitedHealth, Aetna, Anthem Near 50% Value-Based Care Spending at Forbes
Feb-01-17 05:46PM  U.S. proposes 0.25 pct hike in Medicare Advantage payments Reuters
04:34PM  Anthem Joins Aetna, UnitedHealth With Strong Profit Despite ObamaCare
10:35AM  [video]Warren Buffett Is Loved by Hedge Fund Managers Right Now
09:23AM  Anthem (ANTM) Beats Q4 Earnings and Revenue Estimates
08:53AM  5 Stocks Hedge Funds Are Buying at TheStreet
Jan-31-17 07:01PM  Cramer: Use the Decline of Journalism to Buy Bargain Stocks
12:51PM  Aetna offers no guarantees about ACA future beyond 2017
09:30AM  UnitedHealthcare Partners with Camden Coalition to Develop Innovative, Scalable Models of Care for Patients with Complex Health and Social Needs Business Wire
Jan-30-17 05:36PM  Here's What to Expect From Anthem, Cigna, Aetna, Humana Earnings
03:23PM  Trumpcare's other challenge: keeping coverage standards for 156M employer plans
Jan-28-17 12:43AM  [$$] Health Insurer Anthem Has 30% Upside at Barrons.com
Jan-27-17 05:12PM  Express Scripts Falls on Attack From Andrew Left
11:52AM  UnitedHealth Group, Inc. : UNH-US: Dividend Analysis : December 02nd, 2016 (record date) : By the numbers : January 27, 2017
10:00AM  Dow Jones Stays Above 20,000 on Thursday
09:30AM  The Zacks Analyst Blog Highlights: UnitedHealth, Aetna, Molina HealthCare and Centene
07:45AM  4 Growth Dividend Stocks to Buy in February at Motley Fool
06:30AM  Winning Stocks Are Right in Front of Your Eyes: Cramer's 'Mad Money' Recap (Thursday 1/26/17)
Jan-26-17 06:14PM  Cramer uses Warren Buffetts investing method to spot 5 long-term Dow winners at CNBC
02:19PM  United Health Foundation Awards Milwaukee Area Technical College $2.3 Million Grant to Expand Nursing School Capacity Business Wire
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company's UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, individuals, and military service members; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services. It also provides services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; and health services, including commercial health and dental benefits. This segment serves through a network of 1 million physicians and other health care professionals, as well as approximately 6,000 hospitals and other facilities. Its OptumHealth segment offers health management services, including care delivery and management, wellness and consumer engagement, distribution, and health financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The company's OptumInsight segment provides software and information products, and business process outsourcing and support services to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. Its OptumRx segment offers pharmacy care services and programs, including retail network contracting, home delivery and specialty pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILENSKY GAIL RDirectorFeb 23Option Exercise53.785,310285,56760,175Feb 24 04:42 PM
WILENSKY GAIL RDirectorFeb 23Sale162.315,310861,88555,175Feb 24 04:42 PM
BALLARD WILLIAM C JRDirectorFeb 14Option Exercise53.735,000268,65075,391Feb 15 04:50 PM
BALLARD WILLIAM C JRDirectorFeb 14Sale162.685,000813,40070,391Feb 15 04:50 PM
BURKE RICHARD TDirectorJan 31Sale161.6810,0001,616,7501,921,191Feb 02 05:28 PM
BURKE RICHARD TDirectorJan 23Option Exercise52.2189046,4671,931,191Jan 25 04:17 PM
BURKE RICHARD TDirectorDec 29Option Exercise52.575,000262,8501,930,030Jan 03 04:34 PM
Bueno Edson de GodoyDirectorDec 21Option Exercise55.0357,2003,147,716207,817Dec 22 08:55 PM
BURKE RICHARD TDirectorDec 15Sale159.8015,0002,397,0001,925,030Dec 15 04:36 PM
BURKE RICHARD TDirectorDec 08Sale158.6645,0007,139,4891,944,949Dec 09 04:09 PM
ROOS THOMAS EChief Accounting OfficerDec 06Sale157.602,000315,20321,083Dec 08 04:24 PM
WILENSKY GAIL RDirectorNov 17Option Exercise52.545,460286,86760,512Nov 21 04:10 PM
WILENSKY GAIL RDirectorNov 17Sale150.555,460822,00055,052Nov 21 04:10 PM
BALLARD WILLIAM C JRDirectorNov 14Sale151.213,000453,61570,039Nov 16 04:22 PM
WILSON D ELLENEVP Human CapitalOct 21Option Exercise46.1816,275751,58066,635Oct 25 05:07 PM
Shine Kenneth IrwinDirectorOct 21Sale144.9932547,12128,613Oct 25 05:08 PM
WILSON D ELLENEVP Human CapitalOct 21Sale144.1814,3652,071,10552,270Oct 25 05:07 PM
BURKE RICHARD TDirectorSep 14Option Exercise49.325,990295,4421,989,540Sep 15 05:13 PM
BURKE RICHARD TDirectorSep 07Sale135.3140,0005,412,2161,983,550Sep 09 04:52 PM
BALLARD WILLIAM C JRDirectorAug 25Option Exercise52.575,000262,85072,630Aug 29 04:32 PM
BALLARD WILLIAM C JRDirectorJun 16Option Exercise49.435,000247,15072,229Jun 20 04:27 PM
BURKE RICHARD TDirectorJun 16Option Exercise45.415,840265,2192,023,149Jun 20 04:28 PM
BALLARD WILLIAM C JRDirectorJun 16Sale138.585,000692,89567,229Jun 20 04:27 PM
BURKE RICHARD TDirectorMay 13Sale129.3025,0003,232,5332,017,309May 17 04:34 PM
Shine Kenneth IrwinDirectorApr 20Option Exercise25.1662515,72528,680Apr 22 04:18 PM
BALLARD WILLIAM C JRDirectorApr 20Option Exercise45.015,000225,05073,229Apr 22 04:18 PM
BALLARD WILLIAM C JRDirectorApr 20Sale134.875,000674,35568,229Apr 22 04:18 PM
Shine Kenneth IrwinDirectorApr 20Sale132.29962127,26628,055Apr 22 04:18 PM
BURKE RICHARD TDirectorMar 29Option Exercise54.689,290508,0022,041,972Mar 30 04:49 PM
WILENSKY GAIL RDirectorMar 14Option Exercise45.235,420245,13459,025Mar 15 04:59 PM
WILENSKY GAIL RDirectorMar 14Sale124.515,420674,82053,605Mar 15 04:59 PM
WILSON D ELLENEVP Human CapitalMar 07Sale121.514,113499,75349,903Mar 08 04:27 PM
WICHMANN DAVID SPresident & CFOMar 02Option Exercise48.58150,0007,287,000746,536Mar 04 04:29 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E22.78 EPS (ttm)1.23 Insider Own0.20% Shs Outstand2.14B Perf Week-3.26%
Market Cap59.70B Forward P/E18.05 EPS next Y1.55 Insider Trans0.01% Shs Float1.41B Perf Month-5.13%
Income2.53B PEG3.15 EPS next Q0.33 Inst Own37.20% Short Float0.96% Perf Quarter8.85%
Sales22.70B P/S2.63 EPS this Y-20.90% Inst Trans2.69% Short Ratio2.63 Perf Half Y6.12%
Book/sh10.45 P/B2.67 EPS next Y11.21% ROA4.90% Target Price32.69 Perf Year21.65%
Cash/sh- P/C- EPS next 5Y7.24% ROE11.50% 52W Range21.75 - 30.25 Perf YTD3.29%
Dividend1.64 P/FCF- EPS past 5Y-3.30% ROI7.80% 52W High-7.67% Beta0.88
Dividend %5.87% Quick Ratio0.60 Sales past 5Y-12.30% Gross Margin15.10% 52W Low28.41% ATR0.49
Employees6800 Current Ratio0.80 Sales Q/Q5.30% Oper. Margin15.80% RSI (14)42.07 Volatility1.47% 1.65%
OptionableYes Debt/Eq1.07 EPS Q/Q-49.30% Profit Margin11.00% Rel Volume0.79 Prev Close28.37
ShortableYes LT Debt/Eq0.96 EarningsJan 30 BMO Payout132.30% Avg Volume5.15M Price27.93
Recom1.60 SMA20-2.59% SMA500.79% SMA2002.42% Volume4,047,990 Change-1.55%
Jan-31-17Reiterated Barclays Overweight $31 → $33
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-02-14Reiterated RBC Capital Mkts Outperform $71 → $80
Feb-24-17 01:10PM  2016 K-1 Tax Packages for Enterprise Products Partners L.P. Business Wire
11:05AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 10-K, Annual Report
10:09AM  Enterprise Products Partners L.P. 2016 Form 10-K Now Available Business Wire
Feb-23-17 04:15PM  Enterprise Signs Natural Gas Processing Agreements with Producers from Wyomings Green River Basin Business Wire
10:41AM  Energy Transfer says Dakota Access pipeline 99 pct complete Reuters
Feb-22-17 10:06AM  3 Value Stocks Senior Citizens Could Buy Right Now at Motley Fool
09:06AM  79% of Analysts Recommend a Hold for ONEOK
08:24AM  Analyzing US Crude Oil Movement by Rail in November 2016
Feb-21-17 05:23PM  ETEs Implied Volatility Rises ahead of Its Earnings
01:50PM  Houston co. calls for commitments on new pipeline project at bizjournals.com
10:35AM  Is Kinder Morgan Attractively Valued?
Feb-17-17 03:00AM  Houston midstream companies poised for growth on industry optimism at bizjournals.com
Feb-16-17 12:35PM  Will Targa Resources Increase Its Dividend in 2017?
Feb-12-17 10:20AM  Despite Record Market Highs, Insider Buying Jumps: Walgreens, Arconic, Qualcomm, Enterprise Products Partners and More
03:02AM  Insider Buys Highlight for Week of Feb. 6
Feb-10-17 09:07AM  Will Targa Resources Stock Generate High Returns in 2017?
Feb-08-17 10:38AM  How Have Enbridge Energy Partners Price Targets Changed?
Feb-07-17 06:37PM  Enterprise Products Maintains Upward Momentum at Investopedia
10:28AM  NGL Energys Implied Volatility Rose before Its Earnings Results
08:15AM  Post Earnings Coverage as Hess Reported Better Than Expected Results Accesswire
Feb-04-17 11:46AM  1 Energy Stock With a Better Dividend Than Helmerich & Payne, Inc. at Motley Fool
Feb-03-17 10:45AM  Magellan Midstreams Distributable Cash Flow Rose 8% in 4Q16
Feb-02-17 02:35PM  Plains All Americans Segments: Gauging 4Q16 Performance
01:07PM  ETFs with exposure to Enterprise Products Partners LP : February 2, 2017
12:55PM  Plains All Americans 4Q16 Earnings: Behind the Expectations
12:46PM  Enterprise says Seaway pipeline to resume service by Feb. 7
10:53AM  2 Stocks With Better Dividends Than Kinder Morgan, Inc. at Motley Fool
10:15AM  Enterprise Products Partners Management Sees Some Bright Times Ahead in 2017 at Motley Fool
Feb-01-17 04:43PM  Enterprise Products Partners Is Steady as She Goes
01:39PM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: Q4, 2016 By the Numbers : February 1, 2017
12:15PM  [$$] Ruptured U.S. Oil Pipeline May Restart In 'A Few' Days at The Wall Street Journal
11:00AM  Enterprise Products Partners Has a Solid Business
08:20AM  Enterprise Products Partners (EPD) Misses on Q4 Earnings
Jan-31-17 03:35PM  Analysts Are Still Bullish on Enterprise Products Partners
02:05PM  What Drove Enterprise Products Partners 4Q16 Earnings Growth?
12:32PM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: 2016 By the Numbers : January 31, 2017
12:25PM  Enterprise Products Reports 1.5% Rise in Its 4Q16 EBITDA
11:46AM  Whats behind EnLink Midstreams High Implied Volatility?
11:43AM  [$$] Shutdown of Texas Pipeline Boosting Oil Prices at The Wall Street Journal
09:17AM  Decoding US Crude Oil Movement by Rail in October 2016
08:43AM  [$$] Texas Pipeline, Highway Remain Shut After Rupture at The Wall Street Journal
08:28AM  Enterprise Products Partners' Earnings Showed It Kept the Ship Steady Throughout 2016 at Motley Fool
Jan-30-17 09:35PM  Enterprise Products Partners to expand Permian pipeline by 50 percent at bizjournals.com
03:44PM  Edited Transcript of EPD earnings conference call or presentation 30-Jan-17 3:00pm GMT
12:37PM  Top 5 Oil Stocks for 2017 at Investopedia
10:00AM  Enterprise Products Partners LP Earnings Call scheduled for 10:00 am ET today
07:07AM  Q4 2016 Enterprise Products Partners LP Earnings Release - Before Market Open
06:12AM  Enterprise Products misses 4Q profit forecasts
06:05AM  Enterprise to Build Isobutane Dehydrogenation Unit Business Wire
06:00AM  Enterprise Reports 2016 Results Business Wire
Jan-28-17 01:26PM  3 High-Yield Dividend Stocks to Buy in February at Motley Fool
06:23AM  Earnings, Not Politics, Are Still Driving This Market: Cramer's 'Mad Money' Recap (Friday 1/27/17)
Jan-27-17 08:32AM  Should You Buy Enterprise Products Partners (EPD) Ahead of Earnings?
08:05AM  What's in Store for Exxon Mobil (XOM) this Earnings Season?
Jan-26-17 03:45PM  Enterprise Products Breaks Out Before Ex-Dividend Day at Investopedia
07:38AM  63% of Analysts Call Magellan a Buy ahead of Its 4Q16 Results
07:36AM  How Analysts Rate Enterprise Products ahead of Its 4Q16 Earnings
Jan-25-17 10:36AM  What Does Enterprise Products Partnerss Leverage Indicate?
10:19AM  Enterprise Products (EPD) Q4 Earnings: Is a Beat in Store?
09:07AM  What Could Drive Enterprise Products Partnerss Growth?
07:37AM  Could 4Q16 Results Impact Enterprise Products Partners Stock?
Jan-24-17 10:38AM  Falling Contribution of Gas Gathering, Processing to EPDs Income
09:07AM  How Are EPDs Segments Expected to Perform in 4Q16?
07:39AM  Enterprise Products Is Expected to Report Higher 4Q16 Earnings
Jan-20-17 09:30AM  The Zacks Analyst Blog Highlights: Hess, RPC, Chevron, Anadarko Petroleum and Enterprise Products Partners
Jan-19-17 09:45AM  Plains All American to boost capacity on Permian Basin to Corpus Christi pipeline at bizjournals.com
Jan-18-17 07:47PM  Cramer: The yield on this stock could go down on disappointing Kinder Morgan numbers at CNBC
05:20PM  Tech, Energy and Financial Stocks Are Set to Reap Highest Returns for Investors in 2017
03:35PM  Williams Partners Got Upgrade after Financial Repositioning
Jan-17-17 10:48AM  Which Midstream Stocks Have the Highest Implied Volatility?
Jan-13-17 08:54AM  Why You Should (and Shouldn't) Buy Enterprise Products Partners L.P. at Motley Fool
Jan-10-17 03:38PM  Williams Announces Major Financial Repositioning
10:37AM  What Are Analysts Recommending for Enbridge?
10:19AM  Rice Midstream Sees a Sudden Rise in Implied Volatility
Jan-09-17 01:17PM  Will Kinder Morgan Report Higher 4Q16 Earnings?
12:21PM  Is Enterprise Products Setting Up for a Breakout? at Investopedia
10:38AM  DCP Midstream Partners to Become US Largest NGLs Producer
10:37AM  Which MLPs Look Attractive for 2017?
09:06AM  How Does TC PipeLines Valuation Compare to Its Peers?
08:55AM  Enterprise Products Partners to Participate in UBS MLP One-on-One Conference Business Wire
07:36AM  Why Institutional Investors Seem Bullish on MLPs in 2017
Jan-08-17 09:25AM  3 Oil Stocks to Buy in January at Motley Fool
08:11AM  Top Oil Stocks to Buy in 2017 at Motley Fool
08:04AM  Top Gas Stocks to Buy in 2017 at Motley Fool
Jan-06-17 02:35PM  High Leverage Remained a Concern for MLPs in 2016
10:55AM  7 Dividend Stocks to Put on Your Shopping List at Motley Fool
09:09AM  Enterprise Products (EPD) Hikes Quarterly Distribution
07:45AM  7 MLP Giants That Keep Raising Distributions, Even Through Recent Hard Times
Jan-05-17 04:30PM  DryShips Inc.'s Stock Got Absolutely Pulverized in 2016, But the Worst May Be Over at Motley Fool
08:54AM  Enterprise Declares Quarterly Distribution Increase Business Wire
Jan-04-17 02:36PM  Kelley: Still deals to be made in oil sector
11:42AM  Why High Implied Volatility Midstream Stocks Move More Sharply
06:31AM  Tax repatriation favors mid-cap stocks: Pro
Jan-03-17 10:05AM  Stifel Select List Energy MLPs to Buy for 2017
Dec-30-16 10:35AM  How Does Shell Midstream Partnerss Valuation Compare with Its Peers?
07:38AM  Could ETE Further Simplify Its Organizational Structure in 2017?
Dec-28-16 07:35AM  How Many Analysts Are Rating Enterprise Products Partners a Buy?
Dec-27-16 02:43PM  Summit Midstream Partners Is RBC Capitals Top Pick for 2017
12:06PM  Bullish and Bearish Reversals in the Market
10:36AM  What Do the Valuations of EPD, PAA, WPZ, and MMP Indicate?
Enterprise Products Partners L.P., a master limited partnership, provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,500 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas export terminal and NGL import facility. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 478 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,100 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 674 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates refined products pipelines of approximately 4,200 miles; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HACKETT JAMES TDirectorFeb 03Buy28.6533,000945,45033,000Feb 06 04:14 PM
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-3.12 Insider Own0.20% Shs Outstand377.62M Perf Week-0.63%
Market Cap92.66B Forward P/E13.80 EPS next Y17.78 Insider Trans1.68% Shs Float374.18M Perf Month14.89%
Income-1219.50M PEG- EPS next Q3.38 Inst Own82.90% Short Float4.27% Perf Quarter29.94%
Sales14.57B P/S6.36 EPS this Y63.30% Inst Trans-7.47% Short Ratio3.97 Perf Half Y0.86%
Book/sh221.28 P/B1.11 EPS next Y10.83% ROA- Target Price268.74 Perf Year-17.20%
Cash/sh35.02 P/C7.01 EPS next 5Y13.63% ROE- 52W Range184.50 - 301.32 Perf YTD16.84%
Dividend2.80 P/FCF- EPS past 5Y-28.70% ROI- 52W High-18.57% Beta1.15
Dividend %1.14% Quick Ratio- Sales past 5Y26.00% Gross Margin87.20% 52W Low32.99% ATR4.96
Employees31200 Current Ratio- Sales Q/Q7.10% Oper. Margin-12.50% RSI (14)72.42 Volatility1.28% 2.47%
OptionableYes Debt/Eq- EPS Q/Q85.70% Profit Margin- Rel Volume0.46 Prev Close247.03
ShortableYes LT Debt/Eq- EarningsFeb 08 BMO Payout0.00% Avg Volume4.03M Price245.37
Recom2.00 SMA203.88% SMA5012.12% SMA2007.80% Volume1,838,042 Change-0.67%
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Feb-26-17 07:01AM  Insider Q&A: Allergan CEO on impact of limiting price hikes
Feb-24-17 05:13PM  ALLERGAN PLC Files SEC form 10-K, Annual Report
01:21PM  NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017 at Forbes
10:58AM  Top Research Reports for February 24, 2017
Feb-23-17 05:15PM  Eli Lilly & Co.s Revenues in 4Q16
09:41AM  Pernix Therapeutics surges 42% after patent case win against generic from Actavis Labs at MarketWatch
Feb-22-17 09:14PM  Allergan CEO Pushes for Trump to Lead Drug Price Discussions
10:34AM  Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
08:01AM  Allergan to Sponsor Alzheimer's Foundation of America '15th Anniversary National Educating America' Tour PR Newswire
Feb-21-17 10:58AM  Medtronic Earnings Rebound in Third Quarter, Shares Climb
09:30AM  The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson
12:01AM  [$$] Big pharma bets billions on 'silent' liver disease at Financial Times
Feb-17-17 09:00PM  Riddle Me This; Bendable Market: Best of Kass
05:15PM  Stull, Stull & Brody is Investigating Claims on Behalf of Allergans (NYSE:AGN) 401(k) Plan GlobeNewswire
04:22PM  Deals of the Week: Valentine Couplings and Breakups
07:21AM  Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ
Feb-16-17 06:55PM  Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks at Motley Fool
05:38PM  Stress boom to boost drug sales?
12:06PM  David Tepper Invests Heavily in Pharma in 4th Quarter
Feb-15-17 03:03PM  5 Ways Allergan Can Keep Up Momentum
02:54PM  Tepper's Appaloosa Fund Continues Bet on Drug Companies in Q4 2016 at Investopedia
02:18PM  Tepper's Appaloosa triples stake in Allergan
01:24PM  Billionaire Dan Loebs Biggest Q4 Moves Include Bank-Buying Spree, Selling Allergan (AGN) at Insider Monkey
07:00AM  Medicines360 And Allergan Announce Partnership With Health Centers To Help Address Unintended Pregnancies In Areas Impacted By Zika PR Newswire
Feb-14-17 05:52PM  What the Smart Money's buying
05:32PM  David Tepper Increases Wagers on Drug Companies at The Wall Street Journal
05:22PM  Bets on financials, pharma power U.S. hedge funds' strong start to year Reuters
05:19PM  David Tepper's Appaloosa just dropped about $1 billion on 4 pharma stocks
04:54PM  Appaloosa Management snaps up Allergan shares in 4th quarter at MarketWatch
04:09PM  Hologic Follows Allergan, Buying Body-Sculptor Cynosure For $1.65 Bil
03:37PM  Sachem Head's Ferguson to exit Autodesk board, fund gains -letter
02:13PM  ETFs with exposure to Allergan Plc : February 14, 2017
09:45AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Allergan Accesswire
09:24AM  Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit
08:20AM  Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance
08:15AM  Blog Coverage Allergan Acquires ZELTIQ; Set to Expand Presence in the Body Contouring Business Accesswire
07:07AM  Botox-maker Allergan is betting that zapping your fat is worth $4 billion at MarketWatch
06:26AM  New Relic: Cramer's Top Takeaways
Feb-13-17 11:48PM  Asian shares fall back as investors await comments by Yellen
05:57PM  Allergan Paying Nearly $2.5 Billion for ZELTIQ at Investopedia
05:30PM  Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma
05:18PM  Allergan Plc -- Moody's: Allergan's ZELTIQ acquisition credit negative on high pricetag at Moody's
05:11PM  Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%
04:51PM  Zeltiq, US Steel and Chemours rise; Hain Celestial plunges
04:40PM  Why Chemours, Zeltiq Aesthetics, and Vale Jumped Today at Motley Fool
04:34PM  Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 bln
04:05PM  Allergan To Buy Fat-Freezing Zeltiq For $2.5 Bil; Zeltiq Hits Record High
04:00PM  STOCKS HIT ALL-TIME HIGHS: Here's what you need to know
02:24PM  Allergan Acquires Zeltiq Aesthetics for $2.48 Billion at Investopedia
01:26PM  How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More
01:15PM  Allergan Acquires ZELTIQ For $2.47 Billion at Investopedia
12:56PM  Why Zeltiq Aesthetics Stock Is Surging Higher Today at Motley Fool
12:12PM  Allergan Shares Surge After Announcing Acquisition of Zeltiq Aesthetics at TheStreet
11:21AM  [$$] Allergan agrees to buy fat-freezing company for $2.47bn at Financial Times
11:11AM  [video]Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq
11:00AM  Stocks Trade Above Record Closes, Apple Nears All-Time High
10:53AM  UPDATE 2-Allergan to buy Zeltiq Aesthetics for about $2.48 bln
10:31AM  Teva seeks CEO with pharma background to lead recovery efforts Reuters
09:39AM  Morning Movers: Verizon Falls, Teva Jumps, Hain Celestial Craters at Barrons.com
09:34AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of ZELTIQ Aesthetics, Inc. to Allergan plc for $56.50 Per Share is Fair to Shareholders - ZLTQ Accesswire
09:32AM  [$$] Allergan to Buy Fat-Treatment Maker Zeltiq for $2.3 Billion at The Wall Street Journal
09:31AM  Verizon unlimited data is back, Burger King parent Restaurant Brands boosts profit, Allergan buys fat treatment company
08:51AM  Allergan to spend $2.48 B on CoolSculpting provider Zeltiq
08:15AM  Allergan to acquire body contouring company Zeltiq Aesthetics for $2.5 billion at MarketWatch
08:12AM  Allergan is buying a fat-freezing company for $2.5 billion
08:08AM  Allergan agrees to buy Zeltiq for about $2.48 bln
08:00AM  Allergan to Acquire ZELTIQ, Best-in-Class Company in Fast-Growing Body Contouring Segment, for $2.47 Billion PR Newswire
07:45AM  Early movers: AAPL, DD, TEVA, QSR, FDC, HAS, JCP & more at CNBC
05:00AM  [$$] SEC Letter to Allergan Hints at Additional non-GAAP Guidance at The Wall Street Journal
Feb-10-17 07:11PM  Cramer's Exec Cut: Why GE isnt worried about Trumps tra...
07:01PM  Cramer: Why Are People Dumping Such Good Stocks?
05:02PM  Dan Loeb took new stakes in J.P. Morgan, B. of A. and dumped Allergan at MarketWatch
04:10PM  Intercept Bounds To 3-Month High On NASH Trial Edits; Analysts Split
12:02PM  Allergan Plc :AGN-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017
06:44AM  Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi
Feb-09-17 04:15PM  Allergan to Present at The Leerink Partners 6th Annual Global Healthcare Conference PR Newswire
12:45PM  Cramer: Here's the Reason for Allergan's Remarkable Run
12:00PM  AASLD Foundation's Liver Disease Research and Education Initiatives Bolstered by Significant Donation from Allergan PR Newswire
10:10AM  Company News for February 09, 2017
09:40AM  Allergan Plc :AGN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 9, 2017
09:30AM  Today's Research Reports on Gilead Sciences and Allergan Post Earnings Accesswire
08:43AM  How To Invest Like Seth Klarman
06:23AM  Allergan: Cramer's Top Takeaways
Feb-08-17 07:34PM  Cramer Remix: Why you would be an idiot to sell Disney at CNBC
07:18PM  Cramer Remix: The reason you would be an idiot to sell Di...
06:31PM  Is This Market in Trump-Bubble Territory? Cramer's 'Mad Money' Recap (Wednesday 2/8/17)
04:21PM  Allergan Leads Drug Stocks On View-Crushing Q4, 2016, 2017 Guidance
04:01PM  What's Next For Allergan? How About More Acquisitions and a Dividend! at Barrons.com
03:17PM  Allergan PLC (AGN) Launches Campaign To Fight Preventable Blindness In America at Insider Monkey
03:09PM  Edited Transcript of AGN earnings conference call or presentation 8-Feb-17 1:30pm GMT
12:29PM  Allergan's Fourth-Quarter Comments Should Comfort Investors
12:17PM  Allergan says U.S. tax reform unlikely in 2017, sees strong year
11:39AM  Botox Smooths Out Allergan Top and Bottom Line at Investopedia
11:28AM  Stocks Turn Mixed as Oil Prices Rebound, Disney Jumps
11:09AM  [$$] Allergan Results Boosted by New, Established Drugs at The Wall Street Journal
10:39AM  Allergan Tops Revenue Forecast -- Plus Jim Cramer's Comments
09:57AM  Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat
09:54AM  Cramer's Stop Trading: AGN
09:12AM  Market Recon: The Direction of Oil Has Been Somewhat Shocking
09:05AM  Allergan (AGN) Beats Q4 Earnings & Sales; Shares Up
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. Further, the company develops, processes, and markets tissue-based products for use in reconstructive, orthopedic, and urogynecologic surgical procedures to repair soft tissue defects. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
NSC Norfolk Southern Corporation daily Stock Chart
NSC [NYSE]
Norfolk Southern Corporation
IndexS&P 500 P/E21.52 EPS (ttm)5.58 Insider Own0.10% Shs Outstand290.43M Perf Week-2.32%
Market Cap34.87B Forward P/E17.51 EPS next Y6.86 Insider Trans-29.11% Shs Float289.57M Perf Month0.15%
Income1.66B PEG1.81 EPS next Q1.32 Inst Own70.80% Short Float1.02% Perf Quarter16.15%
Sales9.89B P/S3.53 EPS this Y10.30% Inst Trans-0.15% Short Ratio1.49 Perf Half Y31.91%
Book/sh41.71 P/B2.88 EPS next Y11.59% ROA4.80% Target Price118.32 Perf Year67.13%
Cash/sh3.29 P/C36.48 EPS next 5Y11.87% ROE13.50% 52W Range70.23 - 125.00 Perf YTD11.69%
Dividend2.44 P/FCF77.16 EPS past 5Y0.60% ROI9.50% 52W High-3.94% Beta1.28
Dividend %2.03% Quick Ratio0.90 Sales past 5Y-2.40% Gross Margin44.60% 52W Low70.98% ATR2.43
Employees28044 Current Ratio1.00 Sales Q/Q-1.10% Oper. Margin31.10% RSI (14)54.28 Volatility1.68% 1.82%
OptionableYes Debt/Eq0.82 EPS Q/Q15.70% Profit Margin16.80% Rel Volume1.19 Prev Close120.03
ShortableYes LT Debt/Eq0.77 EarningsJan 25 BMO Payout41.90% Avg Volume1.99M Price120.08
Recom2.70 SMA20-0.63% SMA505.19% SMA20024.23% Volume2,367,986 Change0.04%
Jan-26-17Reiterated Cowen Outperform $116 → $130
Jan-18-17Initiated Buckingham Research Neutral
Jan-10-17Downgrade CLSA Outperform → Underperform
Jan-09-17Downgrade Seaport Global Securities Buy → Neutral $101 → $106
Nov-02-16Upgrade Argus Hold → Buy
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-11-16Upgrade BofA/Merrill Neutral → Buy
Jun-03-16Resumed Morgan Stanley Underweight
May-19-16Initiated Credit Agricole Outperform
Apr-25-16Resumed JP Morgan Neutral
Apr-22-16Upgrade UBS Neutral → Buy $84 → $102
Apr-22-16Upgrade Credit Suisse Neutral → Outperform
Apr-22-16Reiterated Cowen Outperform $89 → $101
Apr-22-16Reiterated Barclays Equal Weight $88 → $90
Apr-13-16Resumed BofA/Merrill Neutral
Jan-28-16Upgrade Avondale Mkt Underperform → Mkt Perform
Jan-28-16Reiterated RBC Capital Mkts Sector Perform $84 → $74
Jan-28-16Reiterated Cowen Outperform $93 → $89
Jan-28-16Downgrade Buckingham Research Buy → Neutral
Dec-07-15Upgrade Barclays Underweight → Equal Weight $76 → $95
Feb-22-17 09:06AM  Inside GWRs European Carload Rise in January
Feb-21-17 03:35PM  Inside Norfolk Southerns Intermodal Volumes in the 6th Week
02:06PM  How Higher Coal Volumes Are Lifting Up Norfolk Southern
Feb-16-17 04:15PM  Norfolk Southern to present at Barclays Industrial Select Conference PR Newswire
01:10PM  Is CSX Corporation Stock Gearing Up for Another Huge Year After a Fantastic 2016? at Motley Fool
Feb-15-17 07:00AM  Norfolk Southern's Wide Moat Remains on the Rails at Morningstar
Feb-14-17 11:38PM  CSX railroad wants shareholder vote on hedge fund's demands
02:00PM  Norfolk Southern opens new locomotive maintenance and repair shop in Chicago PR Newswire
Feb-13-17 10:36AM  Why Genesee and Wyomings European Revenue Fell in 4Q16
Feb-09-17 01:04PM  NORFOLK SOUTHERN CORP Financials
Feb-07-17 07:36AM  Why Did Norfolk Southerns Intermodal Volumes Rise?
Feb-06-17 06:06PM  Coal Volume Boosts Norfolk Southerns Carloads
04:05PM  Norfolk Southern to present at Stifel 2017 Transportation and Logistics Conference PR Newswire
12:33PM  NORFOLK SOUTHERN CORP Files SEC form 10-K, Annual Report
Feb-02-17 08:15AM  Post Earnings Coverage as Norfolk Southern's Q4 EPS Rose 18%; Beat Estimates Accesswire
Feb-01-17 08:15AM  Post Earnings Coverage as Kansas City Southern's Reported Q4 Results Accesswire
07:36AM  Which Commodities Boosted Canadian Nationals Carloads?
Jan-31-17 07:38AM  How Do Norfolk Southerns Intermodal Volumes Compare?
Jan-30-17 05:06PM  Why Norfolk Southerns Carloads Increased
09:06AM  Norfolk Southerns Recommendations: Why All the Holds?
07:37AM  NSCs Operating Margins in 4Q16: Why the Elevated Track?
Jan-27-17 04:01PM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
10:37AM  Why Norfolk Southerns Intermodal Revenues Rose in 4Q16
09:07AM  Why Norfolk Southerns General Merchandise Revenue Slid in 4Q16
07:38AM  Why Norfolk Southerns Coal Revenues Slumped in 4Q16
Jan-26-17 05:05PM  What Happened to Norfolk Southerns Revenues in 4Q16?
03:27PM  Inside Norfolk Southerns 4Q16 Earnings Beat
10:26AM  Norfolk Southern Corp. :NSC-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017
10:00AM  Norfolk Southern facilitated $4.0 billion in industrial investment along rail lines in 2016 PR Newswire
08:22AM  Norfolk Southern Beats on Strong Cost Discipline
Jan-25-17 04:15PM  Norfolk Southern sees higher 2017 volumes on coal comeback
03:10PM  CSX shareholder backs Harrison for CEO as activist swoops in
01:04PM  2 Top Railway Companies Raise Their Dividends at Investopedia
11:27AM  Norfolk Southern (NSC) Beats on Q4 Earnings, Misses Sales
11:11AM  Edited Transcript of NSC earnings conference call or presentation 25-Jan-17 1:45pm GMT
09:30AM  Norfolk Southern (NSC) Beats on Q4 Earnings
08:45AM  Norfolk Southern Corp Earnings Call scheduled for 8:45 am ET today
08:15AM  Post Earnings Coverage as Union Pacific's Q4 Results Beat Market Estimates Accesswire
08:11AM  Norfolk Southern tops 4Q profit forecasts
08:11AM  Norfolk Southern quarterly profit rises
08:02AM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:00AM  Norfolk Southern reports fourth-quarter and full-year 2016 results PR Newswire
07:07AM  Q4 2016 Norfolk Southern Corp Earnings Release - 08:00 am ET
04:20AM  European Stocks Books Solid Gains as Earnings, Deal Speculation Boost Sentiment
Jan-24-17 04:59PM  Norfolk Southern names six to vice president responsibilities PR Newswire
04:33PM  /C O R R E C T I O N -- Norfolk Southern Corporation/ PR Newswire
11:49AM  Why CSX Isn't The Only M&A Target In The Rail Space Right Now
Jan-23-17 10:37AM  How Do Norfolk Southerns Intermodal Volumes Compare?
09:08AM  Comparing Norfolk Southerns Carloads
08:25AM  'Dominating the discussion:' Analysts dig into CSX in wake of railroad legend's interest at bizjournals.com
07:39AM  US and Canadian Freight Rail Traffic Up, Mexican Traffic Down
Jan-20-17 07:38AM  Why CSXs Merchandise Revenue Rose in 4Q16
12:19AM  [$$] CSX Investors Cheered by Former Rail Rivals Sudden Switch at The Wall Street Journal
Jan-19-17 07:32PM  [$$] Railroad Maverick Buoys CSX Investors at The Wall Street Journal
04:53PM  The Hot Stock: CSX Surges 23% at Barrons.com
04:14PM  CSX shares explode on activist expectations
04:12PM  CSX Jumps As Outgoing Canadian Pacific CEO Reportedly Eyes Shakeup
03:21PM  Former CP CEO teaming with investor to target CSX railroad
02:42PM  [$$] CSX shares soar as rail industry veteran takes aim at Financial Times
11:07AM  All Aboard the CSX Activist Train at Bloomberg
09:42AM  CSX Surges as Activists Said to Target Railroad for Overhaul at Bloomberg
09:11AM  Canadian Pacific CEO Exit: 'Never A Dull Moment In Calgary'
07:15AM  Canadian Pacific (CP) Down on Q4 Earnings & Revenue Miss
Jan-18-17 09:42PM  Railroad Vet Teams With Activist to Target CSX
07:49PM  Canadian Pacific CEO's Early Exit Sends CSX Shares Soaring
10:06AM  Norfolk Southern (NSC) Q4 Earnings: What Lies in Store?
08:20AM  CSX Corporation (CSX) Beats on Q4 Earnings and Revenues
07:37AM  These Huge Declines Pulled Down CSXs Carloads in the First Week of 2017
06:50AM  Coverage initiated on Norfolk Southern by Buckingham Research
Jan-17-17 05:35PM  Why Norfolk Southerns Intermodal Volumes Slumped in the First Week of 2017
05:09PM  Transports off the rails?
04:05PM  How Do Norfolk Southerns Carloads Compare to Other US Railroads?
01:01PM  Why Railroad Stocks Won't Run You Over This Earnings Season
Jan-16-17 07:37AM  Why Most Analysts Still Rate Union Pacific a Buy
Jan-12-17 07:37AM  How Do Analysts View CSX Corporation ahead of Its 4Q16 Results?
Jan-10-17 10:36AM  Double-Digit Rise in Volumes Minus Coal Pushed CNIs Carloads Up
Jan-09-17 10:38AM  Norfolk Southerns Intermodal Volumes Continue Their Momentum
09:07AM  Fall in Volumes Minus Coal Pulled Down Norfolk Southerns Carloads
Jan-06-17 04:31PM  Dow 20K: What to buy?
Jan-04-17 05:48PM  Gartman's 4 'simple' buys for 2017
09:30AM  Zacks Industry Outlook Highlights: Union Pacific, Canadian Pacific, Canadian National Railway, Kansas City Southern and Norfolk Southern
09:30AM  Zacks Industry Outlook Highlights: Kansas City Southern, Norfolk Southern, Canadian National Railways, Union Pacific and CSX
Jan-03-17 04:13PM  Merrill Lynchs Top 8 Stock Picks for the First Quarter of 2017
04:05PM  Norfolk Southern to hold fourth-quarter 2016 earnings conference call Jan. 25 PR Newswire
11:19AM  A New Infrastructure ETF For The New Year
11:16AM  Norfolk Southern Corp. : NSC-US: Dividend Analysis : November 04th, 2016 (record date) : By the numbers : January 3, 2017
Jan-02-17 07:37AM  How Does Norfolk Southerns Intermodal Volumes Compare with Industry?
Dec-30-16 06:05PM  Positive Coal Volumes Put Norfolk Southerns Carloads on Track
09:30AM  Zacks Industry Outlook Highlights: Canadian National Railways, Norfolk Southern, CSX, Union Pacific and Kansas Southern
07:10AM  Market Recon: Pension Funds Are a Bigger Deal Than Expelled Diplomats
Dec-27-16 09:06AM  Fall in Coal Volumes Pulls down Canadian Nationals Carloads
Dec-26-16 01:30PM  5 Trade Ideas for Tuesday: Ashland, Biogen, Crown Castle, Monster and Norfolk Southern
09:07AM  Strong Rise in Coal Volumes Failed to Push up CSXs Carloads
07:37AM  Norfolk Southerns Intermodal: Will Trailer Volumes Rise?
Dec-23-16 05:35PM  Which Commodity Groups Pulled Down Norfolk Southerns Carloads?
04:02PM  Intermodal Shines in US Freight Rail Volumes, Railcars Down
Dec-20-16 02:50PM  Pan Am Southern and Pan Am Railways take action to protect services over tracks used with Massachusetts Bay Transit Authority PR Newswire
01:35PM  November Winners: Wide Moat Rated Banks and Railroad Stocks
11:41AM  Why Moat Indices Outperformed Benchmarks in November
07:36AM  Norfolk Southerns Intermodal: Why Trailer Volumes Rose
Norfolk Southern Corporation, together with its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods in the United States. It also transports overseas freight through various Atlantic and Gulf Coast ports. In addition, the company is involved in the operation of scheduled passenger trains; leasing or sale of rail property and equipment; development of commercial real estate; telecommunications; and the acquisition, leasing, and management of coal, oil, gas, and minerals, as well as the transport of automotive and industrial products. As of February 14, 2017, it operated approximately 19,500 route miles in 22 states and the District of Columbia. The company was founded in 1883 and is based in Norfolk, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STEWART MARTA REVP-Finance and CFOFeb 21Sale124.432,331290,04616,156Feb 23 08:02 AM
Hurlbut Thomas EVice President and ControllerFeb 17Option Exercise56.182,836159,3189,877Feb 21 01:46 PM
Hurlbut Thomas EVice President and ControllerFeb 17Sale122.371,475180,4907,100Feb 21 01:46 PM
STEWART MARTA REVP-Finance and CFOFeb 13Option Exercise75.142,370178,08220,857Feb 15 01:52 PM
STEWART MARTA REVP-Finance and CFOFeb 13Sale123.072,370291,67618,487Feb 15 01:52 PM
STEWART MARTA REVP-Finance and CFOFeb 09Option Exercise62.752,607163,57621,094Feb 10 10:57 AM
STEWART MARTA REVP-Finance and CFOFeb 09Sale121.972,607317,97618,487Feb 10 10:57 AM
Galanko William AndrewSVP - Law and Corp. Comm.Feb 06Option Exercise47.765,000238,80023,107Feb 08 09:02 AM
Galanko William AndrewSVP - Law and Corp. Comm.Feb 06Sale119.135,934706,91716,337Feb 08 09:02 AM
STEWART MARTA REVP-Finance and CFOFeb 03Option Exercise47.762,907138,83821,394Feb 06 03:34 PM
Hurlbut Thomas EVice President and ControllerFeb 03Sale120.651,297156,4777,041Feb 06 03:34 PM
STEWART MARTA REVP-Finance and CFOFeb 03Sale120.502,907350,29418,487Feb 06 03:34 PM
BOWLES ERSKINE BDirectorFeb 02Sale119.120133,475Feb 06 03:34 PM
CARP DANIEL ADirectorFeb 02Sale119.120533,886Feb 06 03:34 PM
LOCKHART MICHAEL DDirectorFeb 02Sale119.120193,729Feb 06 03:34 PM
THOMPSON JOHN RDirectorFeb 02Sale119.120163,144Feb 06 03:34 PM
BUSH WESLEY GDirectorFeb 02Sale119.1211183,387Feb 07 11:36 AM
Hurlbut Thomas EVice President and ControllerFeb 01Option Exercise47.7660728,9908,945Feb 03 05:17 PM
Hurlbut Thomas EVice President and ControllerFeb 01Sale118.2660771,7848,338Feb 03 05:17 PM
Squires James AChairman, President and CEOJan 26Option Exercise35.6037,4171,332,11095,709Jan 30 04:30 PM
STEWART MARTA REVP-Finance and CFOJan 26Option Exercise0.00950020,898Jan 30 04:32 PM
Wheeler Michael JosephEVP & Chief Operating OfficerJan 26Option Exercise0.00950012,046Jan 30 04:32 PM
Earhart Cynthia CExec. VP - Admin. and CIOJan 26Option Exercise0.0095005,813Jan 30 04:30 PM
Galanko William AndrewSVP - Law and Corp. Comm.Jan 26Option Exercise0.00950018,848Jan 30 04:30 PM
Hurlbut Thomas EVice President and ControllerJan 26Option Exercise0.0095009,083Jan 30 04:30 PM
Shaw Alan H.EVP & Chief Marketing OfficerJan 26Option Exercise0.0055004,264Jan 30 04:30 PM
Squires James AChairman, President and CEOJan 26Sale119.7734,4174,122,29354,589Jan 30 04:30 PM
Hurlbut Thomas EVice President and ControllerNov 18Sale103.7746948,6677,041Nov 21 03:03 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Option Exercise47.762,700128,9524,759Nov 18 03:30 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Sale103.171,654170,6402,622Nov 18 03:30 PM
Squires James AChairman, President and CEONov 11Option Exercise42.764,676199,93749,643Nov 14 10:41 AM
STEWART MARTA REVP-Finance and CFONov 11Sale100.901,970198,7739,774Nov 14 10:15 AM
STEWART MARTA REVP-Finance and CFONov 10Sale100.082,017201,86111,744Nov 14 10:15 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Option Exercise38.7114,417558,010136,234Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Option Exercise38.714,417170,9604,417Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Sale97.0014,4171,398,449121,817Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Sale99.004,417437,2980Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Option Exercise38.7110,000387,050142,647Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Option Exercise50.744,530229,8524,530Nov 10 09:58 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Sale96.184,530435,6730Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Sale95.4820,8301,988,850121,817Nov 10 09:45 AM
STEWART MARTA REVP-Finance and CFONov 07Sale94.102,023190,3647,824Nov 08 03:43 PM
Hurlbut Thomas EVice President and ControllerNov 07Sale94.461,00094,4617,560Nov 08 03:44 PM
Hurlbut Thomas EVice President and ControllerOct 27Sale91.212,170197,9208,560Oct 28 04:43 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsOct 03Option Exercise59.785,016299,851132,647Oct 04 04:26 PM
STEWART MARTA REVP-Finance and CFOSep 19Option Exercise75.141,33099,93612,127Sep 20 01:58 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 30Option Exercise38.718,557331,199136,188Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 30Sale94.158,557805,642127,631Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 29Option Exercise38.711,44355,851129,074Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 29Sale94.161,443135,866127,631Aug 31 11:43 AM
STEWART MARTA REVP-Finance and CFOAug 25Option Exercise62.751,59399,95310,797Aug 29 10:36 AM
Hurlbut Thomas EVice President and ControllerAug 24Sale92.2885078,43810,730Aug 25 02:30 PM
STEWART MARTA REVP-Finance and CFOAug 19Sale91.541,562142,9859,204Aug 19 03:48 PM
STEWART MARTA REVP-Finance and CFOAug 18Sale91.581,502137,55310,766Aug 19 03:48 PM
Hurlbut Thomas EVice President and ControllerAug 17Option Exercise38.711,01739,36312,597Aug 18 04:52 PM
Hurlbut Thomas EVice President and ControllerAug 17Sale89.301,01790,81811,580Aug 18 04:52 PM
Hurlbut Thomas EVice President and ControllerAug 03Sale88.3552846,64711,580Aug 04 11:59 AM
Hurlbut Thomas EVice President and ControllerMay 05Sale89.9266860,07012,203May 06 02:24 PM
Earhart Cynthia CExec. VP - Admin. and CIOApr 25Option Exercise49.566,500322,1086,500Apr 26 04:51 PM
Earhart Cynthia CExec. VP - Admin. and CIOApr 25Sale90.046,500585,2480Apr 26 04:51 PM
Wheeler Michael JosephEVP & Chief Operating OfficerApr 22Option Exercise57.562,436140,21411,715Apr 26 10:50 AM
AET Aetna Inc. daily Stock Chart
AET [NYSE]
Aetna Inc.
IndexS&P 500 P/E20.11 EPS (ttm)6.41 Insider Own0.10% Shs Outstand352.97M Perf Week-0.40%
Market Cap45.52B Forward P/E13.19 EPS next Y9.78 Insider Trans-8.94% Shs Float348.01M Perf Month8.25%
Income2.27B PEG1.46 EPS next Q2.35 Inst Own92.50% Short Float1.46% Perf Quarter0.63%
Sales63.16B P/S0.72 EPS this Y-5.50% Inst Trans0.28% Short Ratio1.60 Perf Half Y9.10%
Book/sh50.81 P/B2.54 EPS next Y10.45% ROA3.40% Target Price139.81 Perf Year18.92%
Cash/sh50.98 P/C2.53 EPS next 5Y13.74% ROE12.90% 52W Range104.33 - 136.22 Perf YTD4.21%
Dividend2.00 P/FCF14.69 EPS past 5Y4.20% ROI7.40% 52W High-5.32% Beta0.61
Dividend %1.55% Quick Ratio- Sales past 5Y13.30% Gross Margin- 52W Low23.62% ATR2.49
Employees49500 Current Ratio- Sales Q/Q4.50% Oper. Margin7.30% RSI (14)62.16 Volatility1.82% 1.88%
OptionableYes Debt/Eq1.16 EPS Q/Q-56.90% Profit Margin3.60% Rel Volume0.74 Prev Close129.73
ShortableYes LT Debt/Eq1.06 EarningsJan 31 BMO Payout15.50% Avg Volume3.19M Price128.97
Recom2.20 SMA205.00% SMA504.67% SMA2008.88% Volume2,361,284 Change-0.59%
Jan-24-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-04-17Initiated Piper Jaffray Neutral
Nov-14-16Downgrade Bernstein Outperform → Mkt Perform
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Jun-16-16Initiated Bernstein Outperform
Apr-29-16Reiterated RBC Capital Mkts Outperform $140 → $144
Feb-02-16Reiterated Wedbush Neutral $130 → $120
Feb-02-16Reiterated RBC Capital Mkts Outperform $142 → $140
Jan-08-16Downgrade Jefferies Buy → Hold
Dec-16-15Initiated Credit Suisse Neutral
Sep-18-15Upgrade Cantor Fitzgerald Hold → Buy
Sep-16-15Initiated JP Morgan Overweight
Sep-08-15Upgrade RBC Capital Mkts Sector Perform → Outperform $159 → $162
Jul-30-15Upgrade BofA/Merrill Neutral → Buy $132
Jul-06-15Downgrade FBR Capital Outperform → Mkt Perform $130
Jun-26-15Reiterated Leerink Partners Outperform $145 → $150
Jun-24-15Initiated RBC Capital Mkts Sector Perform $159
Jun-17-15Reiterated Leerink Partners Outperform $135 → $145
May-12-15Reiterated Leerink Partners Outperform $130 → $135
Apr-29-15Reiterated Argus Buy $115 → $130
Feb-26-17 06:00AM  DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Aetna Inc. To Contact The Firm Business Wire
Feb-24-17 04:33PM  [$$] Trump to Meet With Insurance Executives on Repeal of Affordable Care Act at The Wall Street Journal
02:09PM  Affordable Care Act Replacement Bill Leaked
Feb-23-17 05:04PM  5 Things Republicans Want To Change About Obamacare But Might Not Be Able To
01:04PM  AETNA INC /PA/ Financials
Feb-22-17 05:15PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:19PM  AETNA INC /PA/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat
11:36AM  Trump, House Republicans Seek Delay In Healthcare Ruling - Because They're Afraid They'll Win
11:06AM  AET SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017 Business Wire
09:59AM  Since the Merger With Cigna Seems Doomed, What Are We to Think of Anthem?
08:50AM  Health insurer Aetna to spend $3.3B buying back stock
07:59AM  Aetna Announces $3.3 Billion Share Repurchase Program
07:51AM  Aetna enters $3.3 billion accelerated share buyback program at MarketWatch
07:45AM  Aetna Announces $3.3 Billion Accelerated Share Repurchase Business Wire
Feb-21-17 01:45PM  Hedge Funds Bought Financial, Health Care Stocks in Q4
12:32PM  Finding the Bullish and Bearish Reversals
10:48AM  SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) & Lead Plaintiff Deadline: March 27, 2017 GlobeNewswire
10:00AM  Here's a Quick Look At the Heavy Hitters That Struggling Tiffany & Co. Just Added to its Board
08:39AM  Community Health Systems (CYH) Q4 Earnings Beat Estimates
Feb-20-17 06:31PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:03PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aetna Inc. To Contact The Firm Before Lead Plaintiff Deadline PR Newswire
Feb-19-17 05:03PM  Obamacare was 'flawed', but here's what health care should look like after reform: ex-Aetna CEO at CNBC
Feb-18-17 01:25AM  [$$] Baird Sticks With Its Wal-Mart Rating and Target Price at Barrons.com
01:24AM  [$$] Merger's Collapse Could Boost Anthem Stock at Barrons.com
Feb-17-17 05:42PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
05:11PM  Lifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs., The Southern Company and The Western Union Company PR Newswire
04:52PM  Aetna Shares Bounce Back After Close
04:43PM  Aetna Doubles Its Dividend, Adds to Stock Buyback at Investopedia
04:33PM  AETNA INC /PA/ Files SEC form 10-K, Annual Report
04:11PM  Aetna fattens shareholder payout after Humana deal fails
03:34PM  [$$] Aetna Doubles Dividend, Boosts Buyback Plans at The Wall Street Journal
03:31PM  Moody's Jumps into Action as Aetna-Humana Deal Fails
03:20PM  DOJ: UnitedHealth improperly overcharged medicare
02:54PM  Aetna shares down nearly 3% on $4 bln share buyback authorization; doubled quarterly cash dividend at MarketWatch
02:15PM  Aetna Board of Directors Doubles Quarterly Cash Dividend, Authorizes Additional Share Repurchases Business Wire
12:22PM  Today's charts: UnitedHealth, Humana, Aetna, Anthem shares fall
12:03PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:38AM  US STOCKS-Wall St slips as bank, health stocks weigh
11:01AM  AET INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017 GlobeNewswire
10:20AM  DOJ Accuses UnitedHealth Of Overcharging Medicare Advantage
06:45AM  What does the Humana departure from ACA exchanges mean for Obamacare? at bizjournals.com
Feb-16-17 05:41PM  Aetna Inc. -- Moody's affirms Aetna's ratings and confirms Humana's ratings following cancellation of planned merger at Moody's
08:17AM  Aetna CEO: Why the Merger With Humana Fell Apart at MarketWatch
05:57AM  Aetna CEO on Obamacare's 'Death Spiral' at MarketWatch
Feb-15-17 09:02PM  No Valentine's Day love: 2 big insurance deals appear off
07:08PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:16PM  Humana is on the clock for its next move at bizjournals.com
03:53PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Aetna Inc. (AET) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
01:17PM  Trump now owns Obamacare
12:56PM  Humana Health Exchange Departure Puts Pressure on GOP at MarketWatch
11:48AM  Trump administration proposes stricter Obamacare rules Reuters
11:24AM  Aetna CEO: Obamacare in 'Death Spiral' at Bloomberg
11:17AM  [$$] Humana's Withdrawal From Health Exchanges Pressures GOP at The Wall Street Journal
11:00AM  AETNA CEO: The Obamacare exchanges are in a 'death spiral'
09:27AM  Health Insurers' Courtship Ends on Valentine's Day
09:04AM  Aetna CEO says Obamacare individual plans are in "death spiral"
08:57AM  Humana will dump individual health plans and Obamacare, focus on Medicare Advantage at bizjournals.com
08:15AM  Blog Coverage Aetna and Humana Mutually Agree to Part Ways and Move Forward Accesswire
07:07AM  Anthem fires back at Cigna
12:34AM  [$$] Antitrust Rulings Put Chill on Health-Insurance Mergers at The Wall Street Journal
Feb-14-17 09:30PM  2 big insurance breakups on Valentine's Day
09:10PM  10 Things to Know for Wednesday
06:21PM  Aetna, Humana drop merger; Cigna wants to end Anthem deal Reuters
06:12PM  After Failed $37 Billion Merger, Humana Pegs Non-GAAP Earnings at $11
05:22PM  AETNA INC /PA/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive A
05:15PM  Aetna Officially Pulls the Plug on Humana Merger at Investopedia
05:10PM  Two mega-health insurance mergers terminated at bizjournals.com
04:55PM  4 major Colorado health insurers pull the plug on a pair of mega-mergers at bizjournals.com
04:25PM  Humana issues guidance, raises dividend to $0.40
04:00PM  STOCKS HIT NEW HIGHS: Here's what you need to know
03:24PM  Cigna terminates Anthem merger deal, seeks nearly $15 billion in restitution at MarketWatch
12:38PM  Aetna, Humana Call Off $34 Billion Courtship in Bad Start to Valentine's Day
11:57AM  The Clock Is Ticking for Humana at Bloomberg
11:06AM  Humana Gets $1 Billion Check After Merger With Aetna Is Terminated
10:17AM  Aetna and Humana call it quits on potential merger
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Aetna Inc. (AET) and Lead Plaintiff Deadline: March 27, 2017 Accesswire
09:44AM  Mattel hooks up with Alibaba, Aetna and Humana call off merger, GM may sell European division
09:27AM  Humana, Aetna terminate merger deal at bizjournals.com
08:45AM  Aetna, Humana walk away from $34 billion deal after court ruling Reuters
07:51AM  Global stocks mostly lower as investors await Yellen remarks
07:30AM  Aetna, Humana end $34 billion merger agreement at CNBC
07:17AM  Aetna and Humana end merger deal after 19 months at MarketWatch
07:11AM  Aetna Gives Up On Merger, Will Pay Humana $1B Breakup Fee at Forbes
07:09AM  Aetna, Humana Abandon $37 Billion Merger Blocked by Judge at Bloomberg
07:08AM  Aetna, Humana end $34 bln merger agreement Reuters
07:01AM  Aetna, Humana end merger
07:00AM  Aetna and Humana Mutually End Merger Agreement Business Wire
Feb-13-17 08:54PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
05:19PM  Republicans keep changing when Obamacare will be repealed yet health insurers have a deadline coming up at MarketWatch
02:15PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Aetna Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 AET GlobeNewswire
01:30PM  Will Trump be more friendly to mega-deals like Humana's? at bizjournals.com
12:19PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:40AM  INVESTOR ALERT: The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Aetna Inc. Investors and Encourages Investors to Contact the Firm Business Wire
11:00AM  Studies Back ACOs As Tom Price Takes Helm At HHS at Forbes
Feb-11-17 07:44AM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Feb-10-17 10:51PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Aetna Inc. AET GlobeNewswire
03:30PM  Humana still could merge with national insurance powerhouse, analysts say at bizjournals.com
12:05PM  Humana to lay off 260 in Tampa Bay at bizjournals.com
09:30AM  Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products, including pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCarthy Margaret MEVP, Operations & TechnologyFeb 22Sale128.877,9301,021,91148,310Feb 24 04:31 PM
Bertolini Mark TChairman and CEOFeb 03Option Exercise42.57148,1386,306,235391,808Feb 07 04:27 PM
Coye Molly JoelDirectorNov 30Sale131.171,145150,1877,517Dec 02 05:11 PM
Lynch Karen SPresidentNov 11Sale119.5545,0005,379,92651,254Nov 15 04:06 PM
Coye Molly JoelDirectorNov 09Sale116.96862100,8208,662Nov 14 05:33 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesNov 07Sale109.789,1501,004,47812,367Nov 09 04:14 PM
GARTEN JEFFREY EDirectorSep 07Sale116.517,100827,2149,398Sep 09 04:12 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 23Sale120.318,140979,32344,883Aug 24 04:32 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 22Option Exercise72.2640,0002,890,40084,883Aug 24 04:32 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 22Sale120.1937,1884,469,74844,883Aug 24 04:32 PM
McCarthy Margaret MEVP, Operations & TechnologyMay 10Sale114.4539,1694,483,01056,240May 12 06:06 PM
Bertolini Mark TChairman and CEOMay 03Sale114.0033,5103,820,157390,018May 04 04:20 PM
Bertolini Mark TChairman and CEOMay 02Option Exercise39.93106,5704,255,340496,588May 04 04:20 PM
LOVEMAN GARY WEVP, Consumer Health and SvcsMar 15Buy111.458,970999,7089,675Mar 17 04:34 PM
SRE Sempra Energy daily Stock Chart
SRE [NYSE]
Sempra Energy
IndexS&P 500 P/E20.13 EPS (ttm)5.42 Insider Own0.10% Shs Outstand250.39M Perf Week3.01%
Market Cap27.31B Forward P/E21.36 EPS next Y5.11 Insider Trans-22.89% Shs Float249.65M Perf Month6.36%
Income1.36B PEG3.26 EPS next Q1.49 Inst Own83.30% Short Float2.08% Perf Quarter9.70%
Sales9.98B P/S2.74 EPS this Y16.10% Inst Trans-0.71% Short Ratio5.58 Perf Half Y3.61%
Book/sh49.31 P/B2.21 EPS next Y6.06% ROA3.10% Target Price115.07 Perf Year13.48%
Cash/sh2.07 P/C52.73 EPS next 5Y6.17% ROE10.90% 52W Range91.74 - 113.03 Perf YTD8.40%
Dividend3.02 P/FCF- EPS past 5Y13.50% ROI5.70% 52W High-3.49% Beta0.49
Dividend %2.77% Quick Ratio0.40 Sales past 5Y2.50% Gross Margin96.70% 52W Low18.91% ATR1.38
Employees17387 Current Ratio0.40 Sales Q/Q3.20% Oper. Margin16.50% RSI (14)75.01 Volatility1.28% 1.34%
OptionableYes Debt/Eq1.40 EPS Q/Q150.90% Profit Margin13.10% Rel Volume1.16 Prev Close108.51
ShortableYes LT Debt/Eq1.10 EarningsFeb 28 BMO Payout55.60% Avg Volume928.79K Price109.09
Recom2.00 SMA204.95% SMA506.28% SMA2004.63% Volume1,080,576 Change0.53%
Feb-29-16Reiterated Barclays Overweight $111 → $110
Jan-25-16Reiterated RBC Capital Mkts Outperform $119 → $116
May-06-15Reiterated Barclays Overweight $117 → $120
Sep-22-14Reiterated RBC Capital Mkts Outperform $106 → $115
Aug-14-14Reiterated UBS Buy $106 → $111
Apr-14-14Initiated UBS Buy $106
Apr-02-14Reiterated RBC Capital Mkts Outperform $102 → $104
Jan-06-14Reiterated Barclays Overweight $101 → $97
May-28-13Upgrade Barclays Equal Weight → Overweight $85 → $90
Apr-24-13Reiterated Barclays Equal Weight $77 → $85
Apr-23-13Downgrade ISI Group Buy → Neutral
Feb-27-13Reiterated Barclays Equal Weight $70 → $77
Jan-07-13Upgrade ISI Group Neutral → Buy
Jul-23-12Downgrade Argus Buy → Hold
Apr-03-12Reiterated Barclays Equal Weight $60 → $63
Nov-07-11Reiterated RBC Capital Mkts Sector Perform $54 → $57
Jun-24-11Initiated RBC Capital Mkts Sector Perform $55
Apr-08-11Reiterated Barclays Capital Equal Weight $54 → $57
Feb-28-11Downgrade Barclays Capital Overweight → Equal Weight $57 → $55
Dec-10-10Initiated Oppenheimer Perform $56
Feb-24-17 09:00AM  SDG&E Unveils World's Largest Lithium Ion Battery Energy Storage Facility PR Newswire
06:58AM  Will Sempra Energy (SRE) Upset Investors in Q4 Earnings?
Feb-23-17 01:41PM  Sempra Energy Raises Annualized Dividend By 9 Percent PR Newswire
Feb-16-17 02:30PM  SoCalGas to Install up to 60 New Valves in 2017 to Enhance Pipeline System Safety PR Newswire
Feb-15-17 03:15PM  Sempra Energy : SRE-US: Dividend Analysis : December 29th, 2016 (record date) : By the numbers : February 15, 2017
Feb-14-17 09:00AM  Sempra Energy To Report Fourth-Quarter 2016 Earnings Feb. 28 PR Newswire
Feb-13-17 04:41PM  SoCalGas to Feature Biogas Technology and Powerful New Compressed Natural Gas Big Rigs at 50th Annual World Agricultural Expo PR Newswire
Feb-10-17 01:06PM  SoCalGas Declares Preferred Dividends PR Newswire
Feb-09-17 03:02PM  SoCalGas Pilot Biogas Project Selected by U.S. Energy Department for Funding PR Newswire
Feb-08-17 06:05PM  What Analysts Think about PG&E ahead of 4Q16 Earnings
Feb-07-17 04:48PM  Sempra Energy Announces California Utilities' Settlement Agreement For Two-Year Extension Of Cost-Of-Capital Application PR Newswire
04:45PM  SEMPRA ENERGY Files SEC form 8-K, Other Events
Feb-06-17 12:46PM  TransCanada Corporation's 3 Biggest Growth Opportunities at Motley Fool
Feb-02-17 12:05PM  Utility Stocks: Analyzing Returns and Implied Volatilities
10:18AM  Why Is NRG Energys Implied Volatility Up?
Feb-01-17 08:05AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : February 1, 2017
Jan-31-17 03:46PM  SoCalGas and CR&R Environmental Announce Construction of Pipeline to Provide Carbon-Neutral Renewable Natural Gas PR Newswire
Jan-30-17 04:21PM  Sempra to Use Moon-Mission Technology to Back Up Substations at Bloomberg
03:05PM  SoCalGas Offers Tips on Reducing Winter Gas Bills PR Newswire
Jan-26-17 05:50PM  SoCalGas Advisory Lifted PR Newswire
Jan-25-17 01:44PM  SoCalGas says stops natgas withdrawal from Aliso Canyon storage facility
Jan-24-17 05:01PM  SoCalGas says ceases natgas withdrawal from Aliso Canyon storage facility
Jan-23-17 05:15PM  California utilities seek $1 bln for vehicle electrification Reuters
09:45AM  SoCalGas Advisory Now in Effect PR Newswire
Jan-22-17 04:41PM  SoCalGas Announces "SoCalGas Advisory" PR Newswire
Jan-20-17 08:43PM  SDG&E Aims To Reduce Air Pollution By Deploying Electric Vehicle Charging Throughout The Community PR Newswire
Jan-17-17 09:28PM  SoCalGas Statement on California Department of Conservation's Division of Oil, Gas and Geothermal Resources Announcement of Public Meeting PR Newswire
06:46PM  California moves toward reopening Aliso Canyon gas storage field Reuters
04:18PM  California to hold public meeting on Aliso Canyon natgas facility Reuters
Jan-16-17 10:03AM  Mexico's IEnova will invest $800 mln in 2017 on 8 projects - CEO
Jan-11-17 02:42PM  SoCalGas Announces Funding for Demonstration of Mobile CNG Refueling Solution Developed by Onboard Dynamics, Inc. PR Newswire
Jan-10-17 06:03PM  SoCalGas to Use Fiber Optic Technology to Monitor Pipelines in Real Time PR Newswire
10:10AM  Houston area dominates list of best energy cos. to work for in the U.S. at bizjournals.com
Jan-03-17 04:36PM  SDG&E President, Scott D. Drury, Begins Role PR Newswire
Dec-30-16 07:37AM  SRE, EIX, and PCG: Analyzing Utilities Current Valuations
Dec-29-16 09:08AM  Whats Next for Sempra Energy Stock?
07:37AM  Analysts Expect a Handsome Upside for Sempra Energy in 2017
Dec-28-16 07:50AM  Sempra Energy breached its 50 day moving average in a Bearish Manner : SRE-US : December 28, 2016
Dec-20-16 03:29PM  SoCalGas Lifts "SoCalGas Advisory" PR Newswire
Dec-19-16 02:14PM  SDG&E Urges Customers To Be On "High Alert" For Scam Artists PR Newswire
08:29AM  Sempra Energy (SRE) Unit Buys Ventika Facility in Mexico
Dec-18-16 08:59PM  SoCalGas Issues "SoCalGas Advisory" PR Newswire
Dec-16-16 01:07PM  Sempra Energy Declares Common Dividend PR Newswire
Dec-15-16 06:24PM  Sempra Energy Unit IEnova Completes Acquisition Of Ventika Wind Generation Facilities In Mexico PR Newswire
04:43PM  SDG&E To Upgrade Infrastructure In Orange County To Improve Reliability And Public Safety PR Newswire
12:33PM  SoCalGas Completes More than 700,000 Safety Checks in First Year of Meter Inspection Program PR Newswire
Dec-14-16 06:38PM  SDG&E Transforming Vehicle Fleet PR Newswire
02:23PM  MIT Wins Peeptrade's Global Investment Challenge
11:13AM  Sempra Energy Value Analysis (NYSE:SRE) : December 14, 2016
Dec-13-16 07:26AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : December 13, 2016
Dec-08-16 08:46AM  Hedge Funds Are Selling Sempra Energy (SRE) at Insider Monkey
Dec-06-16 03:17PM  Clean Energy Milestone: 100,000th Private Solar Array Connected To SDG&E's Power Grid PR Newswire
03:09PM  In a National First, SoCalGas and University of California Irvine Successfully Test Innovative Technology that Stores Renewable Energy PR Newswire
Dec-04-16 11:57AM  Weekly Top Insider Buys Highlight for the Week of Dec. 2
Dec-01-16 04:25PM  Calif. expects to complete Aliso Canyon natgas review in early 2017 Reuters
Nov-30-16 05:41PM  SoCalGas Announces "SoCalGas Advisory" Conservation Notification Program to Reduce Risk of Natural Gas Shortages This Winter PR Newswire
02:37PM  SoCalGas Declares Preferred Dividends PR Newswire
01:39PM  Heavy Insider Selling at Invesco Ltd. (IVZ) and Las Vegas Sands Corp. (LVS), Plus Insider Buying at 3 Other Companies at Insider Monkey
Nov-29-16 07:55PM  Port Arthur LNG Files Federal Application To Construct Natural Gas Liquefaction And Export Facilities In Texas PR Newswire
Nov-23-16 09:17PM  Sempra quits talks on Odebrecht Peru pipeline, partners scramble
06:03PM  Sempra drops bid for Odebrecht pipeline in Peru, Techint in talks
04:36PM  Media Statement On Peru Pipeline PR Newswire
03:31PM  Techint says still in talks to buy Odebrecht Peru pipeline stake
Nov-19-16 11:15AM  Peru eyes new auction for natgas pipeline contract in 2017-govt
Nov-18-16 02:10PM  Peru considers rescinding Odebrecht's pipeline contract -source
01:36AM  "Team SoCalGas" Sponsors 2016 United Way HomeWalk; Largest Participant With Over 1,300 Walkers And More Than $151,000 In Contributions PR Newswire
Nov-15-16 05:10PM  SEMPRA ENERGY Files SEC form 8-K, Change in Directors or Principal Officers
Nov-14-16 03:00PM  SoCalGas Deploys Sensors to Detect Methane and Enhance Public Safety PR Newswire
02:29PM  ETFs with exposure to Sempra Energy : November 14, 2016
Nov-11-16 05:42PM  SoCalGas Takes Part in "Utilities United Against Scams Day" To Help Protect Customers Against Fraud PR Newswire
Nov-08-16 05:00PM  LA County supervisors to vote on restricting Aliso Canyon gas injection
01:04PM  SEMPRA ENERGY Financials
Nov-07-16 03:22PM  Sempra Energy's Bad News About Cameron LNG Trumped Decent Earnings Results at Motley Fool
Nov-04-16 01:05PM  ETFs with exposure to Sempra Energy : November 4, 2016
Nov-03-16 09:02PM  Mexico's IEnova increases credit line with banks to $1.17 bln Reuters
09:25AM  Sempra Energy :SRE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016
Nov-02-16 10:39PM  Edited Transcript of SRE earnings conference call or presentation 2-Nov-16 3:00pm GMT -5.24%
10:58AM  Sempra Energy (SRE) Beats on Q3 Earnings, Keeps '16 View
10:44AM  SEMPRA ENERGY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
10:38AM  [$$] Sempra Energy Profit Soars, but Revenue Misses Expectations at The Wall Street Journal
09:57AM  Sempra Energy (SRE) Beats on Q3 Earnings, Revenues Miss
08:40AM  Sempra beats 3Q profit forecasts
08:30AM  Sempra Energy Reports Increased Third-Quarter Earnings PR Newswire
07:07AM  Q3 2016 Sempra Energy Earnings Release - 08:30 am ET
Nov-01-16 09:50PM  Utility asks to resume operations a year after well blowout
06:00PM  SoCalGas Requests Regulatory Approval to Replenish Natural Gas Supply at Aliso Canyon Storage Facility PR Newswire
07:29AM  FirstEnergy (FE) Q3 Earnings: Stock to Post a Beat Again?
Oct-31-16 10:46AM  How These Utilities Stocks are Faring? -- TerraForm Power, Sempra Energy, Talen Energy, and TerraForm Global PR Newswire
08:53AM  Sempra Energy (SRE) Q3 Earnings: Stock to Beat Estimates?
08:50AM  Why Sempra Energy (SRE) Might Surprise This Earnings Season
Oct-27-16 05:12AM  Your best investment bets for 2017 are in emerging markets at MarketWatch
Oct-26-16 08:17AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : October 26, 2016
Oct-24-16 02:20PM  SoCalGas Committed to Assisting Customers with Serious Medical Conditions PR Newswire
Oct-19-16 07:30PM  Sempra Energy To Report Third-Quarter 2016 Earnings Nov. 2 PR Newswire
01:32PM  (OFFICIAL)-SoCalGas completes most well tests at Calif. Aliso Canyon natgas facility
11:37AM  SoCalGas completes well tests at Calif. Aliso Canyon natgas facility
07:00AM  SoCalGas Provides Update on Infrastructure, Technology, and Safety Enhancements at the Aliso Canyon Natural Gas Storage Facility PR Newswire
Oct-17-16 11:47PM  Sempra Energy's IEnova Unit Announces Full Exercise Of Over-Allotment Options PR Newswire
Oct-14-16 05:12PM  SEMPRA ENERGY Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:28AM  [$$] Sempra's Mexican Unit IEnova Sells Shares to Fund Expansion at The Wall Street Journal
Sempra Energy operates as an energy services holding company worldwide. The company's San Diego Gas & Electric Company segment transmits and distributes electricity and/or natural gas. As of December 31, 2015, this segment had approximately 1.4 million electric meters and 873,000 natural gas meters. Its Southern California Gas Company segment transmits, distributes, and stores natural gas. As of December 31, 2015, this segment had approximately 5.9 million customer meters. The company's Sempra South American Utilities segment provides electricity distribution services through 13,458 miles of distribution lines, 185 miles of transmission lines, and 36 substations. Its Sempra Mexico segment owns and operates a natural gas-fired power plant and a wind generation facility in Baja California, Mexico; natural gas distribution systems; natural gas pipelines and propane systems; and liquefied natural gas regasification terminals. The company's Sempra Renewables segment develops solar electric generation facilities in Nevada, Arizona, and California, as well as develops wind electric generation facilities in Mexico. Its Sempra Natural Gas segment owns and operates a natural gas distribution utility located in Mobile and Baldwin counties in Alabama; and a natural gas distribution utility in Forrest County, Mississippi. The company primarily serves residential, commercial, and industrial customers. Sempra Energy was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAVIS STEVEN DCorp. Group PresidentFeb 13Sale105.002,233234,46520,567Feb 13 05:18 PM
HOUSEHOLDER JOSEPH ACorp. Group PresidentJan 24Sale102.106,472660,79147,425Jan 24 08:43 PM
REED DEBRA LChairman and CEOJan 23Sale102.3417,3001,770,482127,645Jan 23 07:20 PM
ROWLAND G JOYCESenior VPJan 19Sale102.592,862293,6131Jan 19 02:00 PM
Martin Jeffrey WExecutive VP and CFOJan 10Sale100.954,266430,6730Jan 10 01:57 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Option Exercise61.4112,000736,92059,425Dec 13 04:42 PM
SNELL MARK APresidentDec 12Sale103.0635,0003,607,10037,914Dec 13 04:41 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Sale102.6912,0001,232,28047,425Dec 13 04:42 PM
ROWLAND G JOYCESenior VPDec 08Sale99.1212512,3901Dec 09 04:11 PM
BOECKMANN ALAN LDirectorNov 29Buy101.526,000609,1166,000Nov 29 06:26 PM
MIHALIK TREVOR ISVP, Controller and CAOAug 10Sale106.865,659604,7212,615Aug 10 05:02 PM
RUTLEDGE WILLIAM PDirectorAug 08Option Exercise64.815,000324,05010,838Aug 08 07:52 PM
RUTLEDGE WILLIAM PDirectorAug 08Sale107.205,000536,0005,838Aug 08 07:52 PM
SNELL MARK APresidentMay 06Sale103.9950,0005,199,50072,909May 09 03:44 PM
OUCHI WILLIAM GDirectorMar 04Option Exercise59.155,000295,75021,230Mar 04 05:00 PM
OUCHI WILLIAM GDirectorMar 04Sale97.735,000488,65016,230Mar 04 05:00 PM
DAVIS STEVEN DExecutive Vice PresidentMar 01Sale96.298,500818,46519,890Mar 01 07:20 PM
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E30.48 EPS (ttm)6.02 Insider Own0.30% Shs Outstand213.06M Perf Week1.55%
Market Cap39.08B Forward P/E17.64 EPS next Y10.40 Insider Trans-9.44% Shs Float212.23M Perf Month6.91%
Income1.31B PEG3.00 EPS next Q2.23 Inst Own85.50% Short Float1.68% Perf Quarter9.88%
Sales12.42B P/S3.15 EPS this Y34.00% Inst Trans0.19% Short Ratio3.61 Perf Half Y6.74%
Book/sh35.59 P/B5.15 EPS next Y10.30% ROA5.10% Target Price189.27 Perf Year25.43%
Cash/sh4.40 P/C41.71 EPS next 5Y10.16% ROE16.90% 52W Range142.36 - 182.85 Perf YTD10.79%
Dividend2.92 P/FCF34.13 EPS past 5Y-3.30% ROI6.90% 52W High0.31% Beta1.04
Dividend %1.59% Quick Ratio0.80 Sales past 5Y10.50% Gross Margin48.60% 52W Low28.84% ATR2.14
Employees50900 Current Ratio1.10 Sales Q/Q-2.10% Oper. Margin15.20% RSI (14)78.13 Volatility1.04% 1.26%
OptionableYes Debt/Eq1.45 EPS Q/Q143.80% Profit Margin10.50% Rel Volume0.66 Prev Close182.30
ShortableYes LT Debt/Eq1.19 EarningsFeb 02 BMO Payout44.10% Avg Volume987.61K Price183.42
Recom2.20 SMA202.73% SMA506.17% SMA2007.09% Volume655,644 Change0.61%
Jan-05-17Downgrade Raymond James Strong Buy → Outperform
Jan-03-17Downgrade JP Morgan Overweight → Neutral
Sep-23-16Downgrade Citigroup Neutral → Sell
May-09-16Reiterated RBC Capital Mkts Sector Perform $153 → $169
Feb-11-16Upgrade Deutsche Bank Hold → Buy $155 → $163
Feb-04-16Reiterated RBC Capital Mkts Sector Perform $162 → $153
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-12-15Initiated Citigroup Neutral
Aug-19-15Reiterated Argus Buy $156 → $167
Aug-10-15Reiterated Deutsche Bank Hold $147 → $155
Aug-07-15Reiterated RBC Capital Mkts Sector Perform $150 → $162
Jul-02-15Resumed Barclays Equal Weight $158
Jun-29-15Upgrade UBS Neutral → Buy $159 → $167
Mar-24-15Reiterated Canaccord Genuity Hold $125 → $149
Mar-10-15Initiated UBS Neutral $159
Feb-11-15Reiterated Argus Buy $140 → $156
Feb-06-15Reiterated RBC Capital Mkts Outperform $145 → $150
Oct-08-14Reiterated RBC Capital Mkts Sector Perform $116 → $132
Oct-07-14Upgrade Stifel Hold → Buy $153
Oct-07-14Reiterated Canaccord Genuity Hold $113 → $125
Feb-22-17 08:00AM  BD To Present At Inaugural CECP CEO Investor Forum PR Newswire
06:59AM  BD Veritor System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests PR Newswire
Feb-21-17 06:59AM  BD Partnership Honored by U.S. Chamber of Commerce Foundation at the Health Means Business National Summit with Healthy10 Award PR Newswire
Feb-20-17 06:59AM  BD Demonstrates Synchronized Technology Platform at HIMSS17 PR Newswire
Feb-17-17 08:00AM  BD to Present at Investor Healthcare Conferences PR Newswire
Feb-16-17 08:15AM  Post Earnings Coverage as Becton, Dickinson and Co.'s Revenue Grew 6.1%; Adjusted EPS Gained 19.4% on Currency Neutral Basis Accesswire
06:59AM  BD Initiates New Industry Alliance To Combat Rising Opioid Crisis PR Newswire
Feb-14-17 09:32AM  Becton, Dickinson Launches BD Resolve Early Access Program
Feb-13-17 06:59AM  BD Announces Early Access Program for BD Resolve Single-Cell Analysis Platform PR Newswire
Feb-08-17 01:04PM  BECTON DICKINSON & CO Financials
Feb-06-17 01:42PM  ETFs with exposure to Becton, Dickinson & Co. : February 6, 2017
Feb-03-17 11:48AM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: Q1, 2017 By the Numbers : February 3, 2017
Feb-02-17 01:06PM  BECTON DICKINSON & CO Files SEC form 10-Q, Quarterly Report
11:53AM  Edited Transcript of BDX earnings conference call or presentation 2-Feb-17 1:00pm GMT
10:14AM  Becton, Dickinson (BDX) Beats on Q1 Earnings & Revenues
08:01AM  Early movers: MRK, FB, BDX, CI, M, DLPH, EL & more at CNBC
08:00AM  Becton Dickinson and Co Earnings Call scheduled for 8:00 am ET today
07:43AM  Becton, Dickinson (BDX) Beats Q1 Earnings & Revenues
07:18AM  [$$] Becton Dickinson's Earnings Jump, and It Raises 2017 Outlook at The Wall Street Journal
07:18AM  Market Recon: The Market Has Run as Far as It Could on Hope
07:07AM  Q1 2017 Becton Dickinson and Co Earnings Release - Before Market Open
06:30AM  Becton Dickinson beats Street 1Q forecasts
06:00AM  BD Announces Results For 2017 First Fiscal Quarter PR Newswire
Feb-01-17 08:44AM  Medical Product Earnings Due on Feb 2: BDX, BSX, IDXX, ATHN
Jan-30-17 01:16PM  Becton, Dickinson & Co. : BDX-US: Dividend Analysis : December 09th, 2016 (record date) : By the numbers : January 30, 2017
10:13AM  Becton, Dickinson (BDX) Q1 Earnings: What's in the Cards?
Jan-26-17 11:18AM  BECTON DICKINSON & CO Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
06:59AM  New BD Institute For Medication Management Excellence Aims To Improve Patient Safety And Outcomes Through Collaboration PR Newswire
Jan-23-17 04:30PM  BD Board Declares Dividend PR Newswire
06:59AM  PleurX Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions PR Newswire
Jan-19-17 10:30AM  BECTON DICKINSON & CO Files SEC form 8-K, Entry into a Material Definitive Agreement
Jan-18-17 04:30PM  BD Announces Webcast of Annual Meeting of Shareholders PR Newswire
08:22AM  Becton, Dickinson Commercially Launches Precise WTA Kits
Jan-17-17 06:59AM  BD Launches Reagents to Simplify Single Cell Research PR Newswire
Jan-13-17 09:07AM  Inside Johnson & Johnsons Latest Dividend Payment
Jan-11-17 10:27AM  Becton, Dickinson & Co. Value Analysis (NYSE:BDX) : January 11, 2017
08:15AM  Post Earnings Coverage as AngioDynamics Adjusted EPS Soared 36% Accesswire
08:00AM  BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call PR Newswire
Jan-10-17 07:25AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : January 10, 2017
Jan-09-17 08:00AM  BD to Present at the 35th Annual J. P. Morgan Healthcare Conference PR Newswire
Jan-05-17 05:42PM  Top 7 Dividend Health Care Stocks
07:35AM  How Do Wall Street Analysts View Becton Dickinson?
07:04AM  Becton Dickinson downgraded by Raymond James
Jan-04-17 10:35AM  A Look at Becton Dickinsons Recent Stock Performance
09:05AM  Inside Becton Dickinsons Financial Guidance for 2017
08:01AM  10 Great All-Weather Stocks at Kiplinger
07:35AM  BDs Latest Dividend Payment and Capital Allocation Strategy
Jan-03-17 10:36AM  A Look at BDXs Recent Product Launches
09:06AM  Analyzing the BD Medical Segments Product Pipeline
07:36AM  BDs Medical Segment Performance and Growth Strategy
Jan-02-17 10:37AM  BD Lifesciencess Product Pipeline Could Boost Its Fiscal 2017 Growth
09:07AM  BD Lifesciencess Performance and Core Focus Areas
07:37AM  Becton Dickinsons Long-Term Growth Profile and Expectations
Dec-29-16 12:56PM  Unusual activity: BDX & JBLU
12:48PM  Farr: My top 10 stocks for 2017 at CNBC
Dec-23-16 11:45AM  The 10 Best Dividend Aristocrats for 2017 and Beyond
09:21AM  What Do Analysts Recommend for Baxter International?
Dec-20-16 07:35AM  Inside Edwards Lifesciences Financial Guidance for 2017
Dec-19-16 10:35AM  Understanding the Key Drivers of EWs Critical Care Business Growth
Dec-15-16 06:59AM  BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics PR Newswire
Dec-12-16 06:00AM  5 Investing Ideas From Top Dividend-Stock Fund Managers at Morningstar
Dec-09-16 04:41PM  BECTON DICKINSON & CO Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal
Dec-08-16 12:15PM  ETFs with exposure to Becton, Dickinson & Co. : December 8, 2016
Dec-06-16 01:00PM  These 3 Stocks Just Raised Their Dividends at Motley Fool
Dec-05-16 12:38PM  BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management PR Newswire
10:38AM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events
Dec-02-16 02:49PM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-01-16 05:30PM  BD Announces Pricing of Tender Offers PR Newswire
05:05PM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:11PM  BD Announces Early Tender Results and Upsizing of Maximum Tender Offers PR Newswire
06:59AM  BD Announces Adoption of Windows 10 'Internet of Things' for the Pyxis ES System PR Newswire
06:00AM  BD to Offer Euro-denominated Senior Unsecured Notes PR Newswire
Nov-30-16 09:22PM  Is Becton Dickinson and Co (BDX) A Good Stock To Buy Right Now? at Insider Monkey
04:02PM  Becton Dickinson Lifts Dividend by 11%
Nov-29-16 08:00AM  Upgrading Our Growth Forecast for Becton, Dickinson
Nov-28-16 12:51PM  Medtronic Registers Missed Revenue Estimates Yet Again, Earnings in-Line
11:56AM  ETFs with exposure to Becton, Dickinson & Co. : November 28, 2016
Nov-25-16 08:05AM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: 2016 By the Numbers : November 25, 2016
Nov-23-16 11:53AM  BECTON DICKINSON & CO Files SEC form 10-K, Annual Report
08:30AM  BD to Present at the 28th Annual Piper Jaffray Healthcare Conference PR Newswire
07:13AM  Becton, Dickinson (BDX) Announces 10.6% Dividend Increase
Nov-22-16 11:04AM  Analyzing Strykers Latest Valuation
Nov-21-16 04:15PM  BD Board Increases Dividend PR Newswire
10:04AM  How Is Stryker Moving Forward with International Growth?
Nov-17-16 10:04AM  What Analysts Recommend for MDT ahead of Its Fiscal 2Q17 Results
08:05AM  Medtronics Fiscal 2Q17 Earnings Are Expected to Witness Growth
Nov-16-16 11:56PM  [$$] Caring for a growing world means halting mother and child deaths at Financial Times
06:04PM  Medtronics Revenue Is Estimated to Rise in Fiscal 2Q17
04:04PM  How Has Medtronics Stock Performed Recently?
12:03PM  Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities PR Newswire
Nov-15-16 08:15AM  Post Earnings Coverage as DENTSPLY Sales Surge 49% Accesswire
Nov-14-16 05:21PM  BD Announces 2016 Analyst Day And Webcast PR Newswire
12:56PM  ETFs with exposure to Becton, Dickinson & Co. : November 14, 2016
10:04AM  Portfolio Optimization Strategy Continues to Drive BDs Growth
Nov-11-16 06:04PM  What Were Becton Dickinsons 4Q16 Growth Drivers?
04:11PM  Whats behind Becton Dickinsons Strong Performance in 2016?
Nov-10-16 10:12AM  Eli Lilly and Co (LLY) Gets Dedicated Humulin R U-500 Insulin Syringe From Becton Dickinson at Insider Monkey
06:59AM  BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery PR Newswire
Nov-09-16 01:57PM  Becton Dickinson Releases New Product (BDX) at Investopedia
Nov-08-16 06:59AM  BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin PR Newswire
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Option Exercise72.1244,3643,199,53266,458Feb 16 08:57 AM
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Sale180.0231,4645,664,24622,094Feb 16 08:57 AM
Conroy AlexandreExecutive Vice PresidentFeb 14Sale177.868,5001,511,81023,676Feb 15 11:31 AM
Gallagher John EVP, Corp Finance and TreasurerDec 15Sale168.821,793302,6942,796Dec 16 01:50 PM
Sichak StephenExecutive Vice PresidentDec 05Sale164.442,632432,8067,953Dec 06 01:48 PM
Sichak StephenExecutive Vice PresidentNov 04Option Exercise76.1818,2461,389,98026,892Nov 07 08:52 AM
Sichak StephenExecutive Vice PresidentNov 04Sale176.1010,3521,822,9878,646Nov 07 08:52 AM
Tharby Linda MExecutive Vice PresidentSep 06Option Exercise75.0120,2911,521,95722,146Sep 07 09:17 AM
Tharby Linda MExecutive Vice PresidentSep 06Sale177.2711,7042,074,8259,188Sep 07 09:17 AM
COHEN GARY MExecutive Vice PresidentAug 11Option Exercise76.6451,8333,972,481125,870Aug 12 09:40 AM
COHEN GARY MExecutive Vice PresidentAug 11Sale176.8129,3675,192,37974,037Aug 12 09:40 AM
Gallagher John EVP, Corp Finance and TreasurerJun 13Option Exercise76.183,500266,6306,758Jun 14 10:03 AM
Gallagher John EVP, Corp Finance and TreasurerJun 13Sale169.871,931328,0193,258Jun 14 10:03 AM
Shabshab NabilExecutive Vice PresidentJun 07Option Exercise74.219,055671,97811,363Jun 08 09:35 AM
Shabshab NabilExecutive Vice PresidentJun 07Sale168.755,080857,2506,700Jun 08 09:35 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 17Option Exercise76.2263,2004,817,38660,932May 18 09:37 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 17Sale166.2734,3735,715,19923,734May 18 09:37 AM
FORLENZA VINCENT AChairman, CEO and PresidentMay 13Option Exercise68.6064,5444,427,900207,225May 16 11:39 AM
Sichak StephenExecutive Vice PresidentMay 13Option Exercise72.1222,9151,652,63031,561May 16 10:56 AM
Sichak StephenExecutive Vice PresidentMay 13Sale166.4812,9952,163,4088,646May 16 10:56 AM
FORLENZA VINCENT AChairman, CEO and PresidentMay 13Sale166.1737,9336,303,327172,681May 16 11:39 AM
ORR JAMES FDirectorMay 10Sale167.661,368229,35923,045May 11 09:13 AM
Conroy AlexandreExecutive Vice PresidentMay 09Option Exercise71.8019,8111,422,36835,738May 10 02:26 PM
Lim James CExecutive Vice PresidentMay 09Sale165.605,257870,55912,556May 10 10:48 AM
Conroy AlexandreExecutive Vice PresidentMay 09Sale165.5811,2381,860,78825,611May 10 02:26 PM
Polen Thomas E JrExecutive Vice PresidentMay 06Option Exercise74.3613,256985,65313,087May 09 04:52 PM
Polen Thomas E JrExecutive Vice PresidentMay 06Sale163.907,2421,186,9645,789May 09 04:52 PM
RIMEL REBECCA WDirectorMay 06Sale163.69684111,9646,835May 09 04:02 PM
Hurwitz Jerome VExecutive Vice PresidentMay 06Sale163.583,878634,3633,027May 09 03:54 PM
Strahlman Ellen RSenior Vice PresidentMay 06Sale163.523,019493,6677,218May 09 03:44 PM
HUM Humana Inc. daily Stock Chart
HUM [NYSE]
Humana Inc.
IndexS&P 500 P/E51.22 EPS (ttm)4.05 Insider Own0.20% Shs Outstand149.54M Perf Week-0.70%
Market Cap31.00B Forward P/E17.40 EPS next Y11.91 Insider Trans-54.40% Shs Float148.39M Perf Month2.75%
Income614.00M PEG3.80 EPS next Q2.37 Inst Own94.90% Short Float0.87% Perf Quarter0.91%
Sales54.38B P/S0.57 EPS this Y-51.80% Inst Trans0.24% Short Ratio0.76 Perf Half Y15.95%
Book/sh71.45 P/B2.90 EPS next Y9.05% ROA2.30% Target Price223.21 Perf Year18.11%
Cash/sh25.93 P/C7.99 EPS next 5Y13.48% ROE5.70% 52W Range149.54 - 217.49 Perf YTD1.74%
Dividend1.60 P/FCF25.16 EPS past 5Y-13.60% ROI5.40% 52W High-4.69% Beta0.92
Dividend %0.77% Quick Ratio- Sales past 5Y8.10% Gross Margin- 52W Low38.61% ATR4.78
Employees51600 Current Ratio- Sales Q/Q-3.60% Oper. Margin3.20% RSI (14)56.50 Volatility1.48% 2.16%
OptionableYes Debt/Eq0.40 EPS Q/Q-499.90% Profit Margin1.10% Rel Volume0.99 Prev Close205.01
ShortableYes LT Debt/Eq0.35 EarningsFeb 08 BMO Payout28.20% Avg Volume1.70M Price207.28
Recom2.10 SMA202.44% SMA502.33% SMA20012.15% Volume1,685,817 Change1.11%
Jan-27-17Resumed BofA/Merrill Buy
Jan-24-17Downgrade Stifel Buy → Hold $214 → $210
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Downgrade Cantor Fitzgerald Buy → Hold
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Nov-10-16Upgrade JP Morgan Neutral → Overweight
Oct-13-16Reiterated RBC Capital Mkts Sector Perform $222 → $217
Jul-22-16Reiterated RBC Capital Mkts Outperform $220 → $224
Jul-22-16Reiterated FBR Capital Mkt Perform $220 → $170
Jul-18-16Upgrade Jefferies Hold → Buy $210
Jul-08-16Downgrade JP Morgan Overweight → Neutral $196 → $150
May-05-16Reiterated Stifel Buy $209 → $220
May-05-16Reiterated RBC Capital Mkts Sector Perform $209 → $220
Dec-16-15Initiated Credit Suisse Neutral
Nov-09-15Reiterated RBC Capital Mkts Sector Perform $223 → $215
Sep-16-15Initiated JP Morgan Overweight
Sep-08-15Reiterated RBC Capital Mkts Sector Perform $230 → $223
Jul-30-15Reiterated Barclays Equal Weight $180 → $193
Jul-07-15Reiterated FBR Capital Mkt Perform $150 → $230
Jul-07-15Downgrade Argus Buy → Hold
Feb-24-17 02:09PM  Affordable Care Act Replacement Bill Leaked
Feb-23-17 05:04PM  5 Things Republicans Want To Change About Obamacare But Might Not Be Able To
Feb-22-17 04:41PM  Humana Inc (HUM): Whats Next After The Failed Merger? at Insider Monkey
01:04PM  HUMANA INC Financials
11:36AM  Trump, House Republicans Seek Delay In Healthcare Ruling - Because They're Afraid They'll Win
09:59AM  Since the Merger With Cigna Seems Doomed, What Are We to Think of Anthem?
08:50AM  Health insurer Aetna to spend $3.3B buying back stock
07:35AM  Humana execs sold $66 million in company stock yesterday at bizjournals.com
Feb-21-17 04:30PM  10 Biggest HMOs in USA at Insider Monkey
Feb-18-17 01:25AM  [$$] Baird Sticks With Its Wal-Mart Rating and Target Price at Barrons.com
Feb-17-17 04:52PM  Aetna Shares Bounce Back After Close
04:27PM  UnitedHealth, Health Insurers Fall As DOJ Joins Whistleblower Suit
04:11PM  Aetna fattens shareholder payout after Humana deal fails
03:34PM  [$$] Aetna Doubles Dividend, Boosts Buyback Plans at The Wall Street Journal
03:31PM  Moody's Jumps into Action as Aetna-Humana Deal Fails
12:22PM  Today's charts: UnitedHealth, Humana, Aetna, Anthem shares fall
08:43AM  HUMANA INC Files SEC form 10-K, Annual Report
06:45AM  What does the Humana departure from ACA exchanges mean for Obamacare? at bizjournals.com
Feb-16-17 09:30PM  New Study: Aging Americans Snubbed in Best Picture Films Business Wire
05:41PM  Aetna Inc. -- Moody's affirms Aetna's ratings and confirms Humana's ratings following cancellation of planned merger at Moody's
04:59PM  What Blocked Mergers Mean for Managed Care
03:25PM  What Humana leaving ACA exchanges means for Memphis at bizjournals.com
02:00PM  Caravan Health Enters into Value-Based Agreement with Humana in Kansas, Missouri, Arkansas and Oklahoma Business Wire
11:14AM  Insurance Megadealers Need to Get Creative at Bloomberg
08:17AM  Aetna CEO: Why the Merger With Humana Fell Apart at MarketWatch
05:57AM  Aetna CEO on Obamacare's 'Death Spiral' at MarketWatch
Feb-15-17 09:02PM  No Valentine's Day love: 2 big insurance deals appear off
04:40PM  Fossil and AIG slump, Procter & Gamble and Fortress jump
04:16PM  Humana is on the clock for its next move at bizjournals.com
04:06PM  Amazon, P&G, Humana Get Price-Target Hikes; Under Armour Cut Again
03:17PM  Humana's exit from 2018 Obamacare market sets states and insurers scrambling at CNBC
01:17PM  Trump now owns Obamacare
01:11PM  A Rough 24 Hours for Obamacare at Bloomberg
12:56PM  Humana Health Exchange Departure Puts Pressure on GOP at MarketWatch
12:35PM  Humana, Inc. :HUM-US: Earnings Analysis: 2016 By the Numbers : February 15, 2017
11:48AM  Trump administration proposes stricter Obamacare rules Reuters
11:17AM  [$$] Humana's Withdrawal From Health Exchanges Pressures GOP at The Wall Street Journal
11:01AM  These big Obamacare changes could help insurers, but lead to fewer customers at CNBC
11:00AM  AETNA CEO: The Obamacare exchanges are in a 'death spiral'
09:27AM  Health Insurers' Courtship Ends on Valentine's Day
08:57AM  Humana will dump individual health plans and Obamacare, focus on Medicare Advantage at bizjournals.com
08:15AM  Blog Coverage Aetna and Humana Mutually Agree to Part Ways and Move Forward Accesswire
08:12AM  Investors take the consumer's temperature, Humana bails on Obamacare and turning the Echo into a phone
08:05AM  Early movers: PEP, ANTM, HLT, AMZN, GOOGL, IART & more at CNBC
06:43AM  10 things you need to know before the opening bell
06:01AM  HUMANA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agree
01:25AM  PRESS DIGEST- New York Times business news - Feb 15 Reuters
12:34AM  [$$] Antitrust Rulings Put Chill on Health-Insurance Mergers at The Wall Street Journal
Feb-14-17 09:30PM  2 big insurance breakups on Valentine's Day
06:23PM  Cigna Wants Divorce from Anthem Deal, Sues for Nearly $15 Billion
06:21PM  Aetna, Humana drop merger; Cigna wants to end Anthem deal Reuters
06:12PM  After Failed $37 Billion Merger, Humana Pegs Non-GAAP Earnings at $11
05:54PM  Humana to quit Obamacare exchanges in 2018, providing fuel for Trump's 'repeal' efforts at CNBC
05:44PM  One of the US's largest health-insurance companies is dumping Obamacare; Trump says law 'continues to fail'
05:20PM  Insurer Humana bails on ACA exchange business for 2018
05:15PM  Aetna Officially Pulls the Plug on Humana Merger at Investopedia
05:10PM  Two mega-health insurance mergers terminated at bizjournals.com
04:55PM  4 major Colorado health insurers pull the plug on a pair of mega-mergers at bizjournals.com
04:55PM  Humana Will Leave Obamacare Altogether In 2018 at Forbes
04:34PM  Humana to exit Obamacare exchanges, buy back $2B in stock at MarketWatch
04:15PM  Humana Continues to Build Upon Proven Strategy Following Termination of Merger with Aetna; Provides 2017 Financial Guidance; Announces Capital Deployment Plans Business Wire
04:00PM  STOCKS HIT NEW HIGHS: Here's what you need to know
03:24PM  Cigna terminates Anthem merger deal, seeks nearly $15 billion in restitution at MarketWatch
12:38PM  Aetna, Humana Call Off $34 Billion Courtship in Bad Start to Valentine's Day
11:57AM  The Clock Is Ticking for Humana at Bloomberg
11:06AM  Humana Gets $1 Billion Check After Merger With Aetna Is Terminated
10:36AM  Aetna, Humana call off $34 billion deal
10:17AM  Aetna and Humana call it quits on potential merger
10:03AM  Stocks Open Slightly Lower; Mattel Up On Alibaba Partnership; Mnuchin Confirmed
09:48AM  Humana, Inc. :HUM-US: Earnings Analysis: Q4, 2016 By the Numbers : February 14, 2017
09:44AM  Mattel hooks up with Alibaba, Aetna and Humana call off merger, GM may sell European division
09:38AM  Stocks Move Lower Ahead of Yellen Testimony
09:27AM  Humana, Aetna terminate merger deal at bizjournals.com
08:45AM  Aetna, Humana walk away from $34 billion deal after court ruling Reuters
08:05AM  Companies on the defense over Trump's unpredictability
08:02AM  Forbes: Border tax is a disaster on working families
07:56AM  Early movers: HUM, AET, GM, PLKI, DISCA, GNRC, ITT & more at CNBC
07:51AM  Global stocks mostly lower as investors await Yellen remarks
07:30AM  Aetna, Humana end $34 billion merger agreement at CNBC
07:17AM  Aetna and Humana end merger deal after 19 months at MarketWatch
07:16AM  NO DEAL: Aetna and Humana call off their $34 billion merger
07:11AM  Aetna Gives Up On Merger, Will Pay Humana $1B Breakup Fee at Forbes
07:09AM  Aetna, Humana Abandon $37 Billion Merger Blocked by U.S. Judge at Bloomberg
07:08AM  Aetna, Humana end $34 bln merger agreement Reuters
07:07AM  Humana and Aetna call off $34 billion buyout, citing "current environment"
07:00AM  Humana Announces Termination of Merger with Aetna; Schedules Conference Call with Investors Business Wire
Feb-13-17 05:19PM  Republicans keep changing when Obamacare will be repealed yet health insurers have a deadline coming up at MarketWatch
01:30PM  Will Trump be more friendly to mega-deals like Humana's? at bizjournals.com
07:30AM  4 Trade Ideas in Humana: Bonus Idea
Feb-10-17 03:30PM  Humana still could merge with national insurance powerhouse, analysts say at bizjournals.com
02:46PM  Humana to lay off 260 in Tampa Bay at bizjournals.com
10:37AM  Cigna: A Healthy Pick, Deal or No Deal at Barrons.com
09:30AM  Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
06:15AM  Healthiest Employers: Honoree Kansas City Area Transportation Authority at bizjournals.com
06:02AM  How to Trade 5 Health Insurers Now That Mergers Are Being Blocked
Feb-09-17 05:35PM  Health Insurance Industry Outlook - February 2017
05:06PM  Will Cigna take a stab at another mega merger?
11:55AM  Bankers Face Lost Fees as Anthem-Cigna Deal Is Blocked at The Wall Street Journal
10:10AM  Company News for February 09, 2017
09:05AM  Humana to limit coverage of pricy Biogen drug at bizjournals.com
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment offers Medicare benefits, as well as commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group segment offers commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; and administrative services only products, and health and wellness products to employer groups. It also provides military services, such as TRICARE South Region contract. The Healthcare Services segment offers pharmacy solutions, provider services, home based services, clinical programs, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also provides closed-block long-term care insurance policies. As of December 31, 2016, it had approximately 14.2 million members in medical benefit plans, as well as approximately 7.0 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LeClaire Brian P.SVP & Chief Information Off.Feb 22Option Exercise119.7314,6251,751,00537,157Feb 22 07:59 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 22Sale205.2426,8945,519,6179,289Feb 22 07:59 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerFeb 22Sale205.204,020824,9208,966Feb 22 06:53 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerFeb 22Sale205.734,832994,0908,931Feb 22 06:47 PM
MURRAY JAMES EEVP & COOFeb 22Sale204.699,5231,949,21659,932Feb 22 09:06 PM
MURRAY JAMES EEVP & COOFeb 21Option Exercise132.1046,1676,098,840115,131Feb 22 09:06 PM
BROUSSARD BRUCE DPresident & CEOFeb 21Option Exercise94.6467,6216,399,648197,316Feb 22 06:43 PM
Zipperle Cynthia HVice President, CAO,ControllerFeb 21Option Exercise44.964,213189,3959,834Feb 22 07:15 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsFeb 21Option Exercise102.1697899,90823,589Feb 22 07:18 PM
Huval Timothy S.Senior VP & Chief HR OfficerFeb 21Option Exercise102.165,029513,73742,650Feb 22 07:21 PM
Christopher M TodoroffSr. VP and General CounselFeb 21Option Exercise95.0119,9471,895,18638,978Feb 22 08:09 PM
Christopher M TodoroffSr. VP and General CounselFeb 21Sale205.3324,1404,956,55014,351Feb 22 08:09 PM
BILNEY JODY LSVP & Chief Consumer OfficerFeb 21Sale204.726,0871,246,13817,926Feb 22 08:05 PM
Huval Timothy S.Senior VP & Chief HR OfficerFeb 21Sale204.9425,5295,231,82416,634Feb 22 07:21 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsFeb 21Sale205.2813,4522,761,4179,650Feb 22 07:18 PM
Zipperle Cynthia HVice President, CAO,ControllerFeb 21Sale204.674,213862,2835,621Feb 22 07:15 PM
BROUSSARD BRUCE DPresident & CEOFeb 21Sale205.23104,25621,396,77292,086Feb 22 06:43 PM
JONES DAVID A JR/KYDirectorFeb 21Sale205.0427,0005,536,16927,050Feb 23 11:58 AM
MURRAY JAMES EEVP & COOFeb 21Sale205.5042,7168,778,1460Feb 22 09:06 PM
MURRAY JAMES EEVP & COOFeb 21Sale205.2070,33214,431,98234,789Feb 22 09:06 PM
Christopher M TodoroffSr. VP and General CounselFeb 18Option Exercise0.0010,651023,675Feb 22 08:09 PM
BILNEY JODY LSVP & Chief Consumer OfficerFeb 18Option Exercise0.0010,651028,577Feb 22 08:05 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 18Option Exercise0.007,889025,734Feb 22 07:59 PM
Huval Timothy S.Senior VP & Chief HR OfficerFeb 18Option Exercise0.0010,651042,169Feb 22 07:21 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsFeb 18Option Exercise0.005,128024,499Feb 22 07:18 PM
Zipperle Cynthia HVice President, CAO,ControllerFeb 18Option Exercise0.002,58406,542Feb 22 07:15 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerFeb 18Option Exercise0.007,889016,855Feb 22 06:53 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerFeb 18Option Exercise0.0010,651018,439Feb 22 06:47 PM
BROUSSARD BRUCE DPresident & CEOFeb 18Option Exercise0.0053,2570155,108Feb 22 06:43 PM
MURRAY JAMES EEVP & COOFeb 18Option Exercise0.0017,357076,798Feb 22 09:06 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerJan 06Option Exercise0.0014,827015,542Jan 10 01:48 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsDec 22Option Exercise123.7611,7491,454,10328,432Dec 23 01:11 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerDec 20Option Exercise81.808,500695,25813,760Dec 22 09:57 AM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerDec 15Option Exercise0.001,09205,811Dec 19 03:31 PM
LeClaire Brian P.SVP & Chief Information Off.Dec 15Option Exercise0.001,092018,393Dec 19 03:21 PM
Kane Brian ASVP & Chief Financial OfficerDec 15Option Exercise0.001,53901,539Dec 19 03:16 PM
MURRAY JAMES EEVP & COODec 15Option Exercise0.002,383060,621Dec 19 02:53 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsDec 15Option Exercise0.001,092017,220Dec 19 02:41 PM
BILNEY JODY LSVP & Chief Consumer OfficerDec 15Option Exercise0.001,539018,687Dec 19 02:14 PM
Christopher M TodoroffSr. VP and General CounselDec 15Option Exercise0.001,539014,179Dec 19 01:57 PM
BROUSSARD BRUCE DPresident & CEODec 15Option Exercise0.008,6890106,113Dec 19 01:40 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerDec 15Option Exercise0.001,09201,092Dec 19 01:14 PM
KAY CHRISTOPHER ESVP & Chief Innovation OfficerDec 15Option Exercise0.001,09201,092Dec 19 01:03 PM
Huval Timothy S.Senior VP & Chief HR OfficerDec 15Option Exercise0.001,539032,277Dec 19 12:49 PM
Zipperle Cynthia HVice President, CAO,ControllerDec 15Option Exercise0.0079404,235Dec 19 12:24 PM
BILNEY JODY LSVP & Chief Consumer OfficerDec 02Option Exercise76.4314,8681,136,361